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Biofilms are ubiquitous in medical, environmental, and engineered microbial sys-
tems. The majority of naturally occurring microbes grow as mixed species biofilms.
These complicated biofilm consortia are comprised of many cell phenotypes with
complex interactions and self-organized into three-dimensional structures. Approxi-
mately 2% of the US population suffers from non-healing chronic wounds infected by
a combination of commensal and pathogenic bacteria whereas about 500,000 cases
of Clostridium difficile infections (CDI) are reported annually. These polymicrobial
infections are often resilient to antibiotic treatment due to the nutrient-rich environ-
ments within the biofilms and species interactions that promote community stability
and robustness. This thesis focuses on developing metabolic modeling framework to
study the interactions and the spatial/temporal organizations in the biofilms. The
modeling framework is based on solving genome scale metabolic reconstructions of
considered species to predict species abundances, growth rates and byproduct secre-
tions.
vi
The spatiotemporal modeling framework accounts for the nutrient concentration
gradients in the biofilm system. Spatiotemporal biofilm metabolic models were for-
mulated by combining genome scale metabolic reconstructions of considered species
with uptake kinetics for available nutrients and reaction-diffusion type equations for
species biomass, supplied substrates and synthesized metabolic byproducts. The re-
sulting partial differential equations embedded with linear programs were discretized
in the space and integrated using a dynamic flux balance method. This framework
was used to calculate the spatial and temporal variations in the species, nutrient and
byproduct concentrations in biofilms. This framework was applied to analyze the
biofilms associated with chronic wound infections, CDI and environmental biofilms.
The chronic wound biofilm model was comprising of two most dominant species,
Pseudomonas aeruginosa and Staphylococcus aureus. The model predicted partition-
ing of species based on their nutritional niches consistent with in vitro experiments.
The CDI biofilm model was comprising of representative species from three most
common phyla in gut Bacteroidetes thetaiotaomicron, Faecalibacterium prausnitzii,
Escherichia coli and pathogen C. difficile. The simulation results were used to study
the interspecies interactions, the spatial partitioning in the biofilms and important
crossfeeding relationships within the community. These predictions would be useful
in devising effective antibiotic treatment strategies to cure the biofilm infections as-
sociated with chronic wounds and C. difficile. The environmental biofilm model for
cyanobacteria and heterotrophs was developed and validated with the experimental
results, this model was used to evaluate the community dynamics under extreme
environmental conditions.
The steady state community modeling framework considered biofilm as a well-
mixed homogeneous system at steady state. This framework can be used when
the community is large and can not be easily solved as a spatiotemporal biofilm.
Steady state in silico community models were formulated by combining genome scale
vii
metabolic reconstructions of the considered species. The community models were
solved using SteadyCom method. This method uses community flux balance analysis
to calculate the relative abundance of each species with an objective of maximiz-
ing the community growth rate. A 12 species chronic wound community metabolic
model covering 74% of 16S rDNA pyrosequencing reads of dominant genera from
2,963 chronic wound patients was developed. The community model was used to
predict species abundances averaged across this large patient population. The simu-
lation results from this study were used to identify putative mutualistic interactions
between bacteria that could be targeted to enhance treatment efficacy. The frame-
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1.1 Microbial communities and biofilms
Biofilms are thin slimy layers of bacteria growing on either living or non living
surfaces. Bacteria produce slimy extracellular polymeric substances and form a three
dimensional robust structure around them. The bacteria living inside the biofilms
interact with each other using mutualistic, syntrophic, commensal or antagonistic
strategies to compete for and efficiently utilize available nutrients [2–5]. Microbes
residing in biofilms exhibit phenotypes distinct from planktonic growth. For in-
stance, bacteria in biofilms can tolerate antimicrobial agent concentrations 10,000
times higher than the same microbes grown planktonically [6, 7].
Microbial biofilms are critically important in medical, environmental and engi-
neered biological systems. For example, the human gut microbiome has emerged as a
major focus for biomedical research with mounting evidence suggesting unhealthy gut
flora biofilms are associated with illnesses including autoimmune diseases, colorectal
cancer and inflammatory bowel disease [8–13]. Environmental microbial biofilm con-
sortia form the basis of global nutrient cycles from nitrogen fixation to carbon fluxes
[14, 15]. Additionally, the study of natural biofilms has recently gained in popular-
ity due to their efficient organization and ability, through synergistic interactions, to
optimize multiple tasks simultaneously like the deconstruction of complex, recalci-
trant plant materials into simple sugars. A major goal of current biofuels research
is to engineer synthetic microbial communities that mimic these naturally occurring
biofilms for biomass conversion to renewable liquid fuels [16]. While foundational to
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the vast majority of microbial life on the planet, the basic design principles of con-
sortial biofilms are still poorly understood due largely to the complexity of naturally
occurring systems [4, 5].
1.2 Microbial communities in human health and diseases
The microbial communities in the biofilms play both positive and negative roles
in human health. For example, the gut microbiota comprise a complex ecological
system that maintains a critical symbiotic relationship with the human host [17, 18].
The microbiota provide essential nutrients such as short-chain fatty acids (SCFAs;
acetate, butyrate and propionate), support colonization resistance to pathogens, par-
ticipate in the degradation of toxic compounds and regulate the immune responses
[19–23]. Bacteroidetes and Firmicutes are the two dominant phyla in the healthy gut,
comprising approximately 90% of the community. Other important but less abun-
dant phyla are Proteobacteria, Actinobacteria, Euryarchaeota and Verrucomicrobia
as well as Eukaryota such as fungi [24, 25]. The gut microbiota composition can be
altered by numerous factors including diet, antibiotic treatment, stress and lifestyle
[26, 27]. Dietary components including carbohydrates, protein, fat and host secretions
such as primary bile acids and nitrate play a particularly important role in shaping
microbiota abundances [28–33].
Unhealthy alterations of the gut microbiota are termed as dysbiosis and represent
imbalances in species abundances associated with diseases such as inflammatory bowel
diseases, Crohn’s disease, obesity and diabetes [34–36]. The anaerobic bacterium
Clostridium difficile is an opportunistic human pathogen responsible for infections
in the colon of the human gastrointestinal tract [37]. Various studies have reported
that 3%–15% of healthy adults are asymptomatically colonized with C. difficile [38–
44]. Commensal species in healthy gut usually provide resistance against C. difficile
pathogenic colonization. C. difficile infection (CDI) is most common in patients previ-
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ously treated with broad spectrum antibiotics that disrupt the healthy gut microbiota
and reduce competition for available nutrients [45], resulting in dysbiosis conducive
to C. difficile propagation [46–49]. CDI symptoms can range from mild diarrhea to
severe and life threatening colitis [37, 50]. C. difficile virulence is attributable to the
secretion of the high molecular weight toxins A and B that promote epithelial tissue
damage and rapid fluid loss. Some C. difficile strains have developed resistance to
common antibiotics while also exhibiting more severe pathogenicity [51]. CDI has
become particularly common in hospital settings due to the ability of C. difficile to
form spores that adhere to surfaces and resist common disinfectant protocols. Studies
estimate that almost 500,000 CDI cases occur within the U.S. annually [52], resulting
in 29,000 deaths and over $4.8 billion in associated costs in acute care facilities alone
[53].
The other example of negative bacterial biofilm colonization is non healing chronic
wound. Chronic wounds are defined as a host-pathogen environment that has failed
to proceed through a timely healing process. Chronic wounds are often colonized by
microorganisms growing as biofilms on a complex mixture of wound exudate [54–61].
An estimated 2% of the U.S. population (6 million people) have a non-healing chronic
wound with treatment costing more than $25 billion per year [62–64]. Chronic wounds
are typically colonized by consortia comprised of different microbial species [55, 54,
56, 65, 66]. Polymicrobial infections have been reported to have elevated mortality
rates relative to monocultures [67], and in vivo rabbit model systems demonstrated
that consortia prevented wound healing compared to their respective monocultures
[61, 68].
1.3 Metabolic modeling of microbial communities
Multispecies biofilms are sufficiently complex to preclude detailed understanding
through traditional experimental techniques developed for planktonic cultures. A
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primary challenge is to understand the complex interactions between the species and
the extracellular environment [69]. In silico metabolic models are powerful tools for
the analysis of how host environment impacts species interactions and community
stability, composition and robustness [70–73]. These modeling frameworks need prior
knowledge of the types of interspecies interactions such as mutualism, commensalism
or competition and they can be extended to study interactions between maximum
five species.
To better understand the metabolic interactions between the species and the en-
vironment, we have developed two modeling frameworks based on homogeneity and
heterogeneity in the biofilm system considered. The first approach is community
modeling framework based on SteadyCom method [74] for efficiently simulating large
community models to predict the growth rate, species abundances and metabolite
crossfeeding rates between species. This in silico computational method is used for
efficiently simulating complex and realistic host-associated bacterial communities,
connecting host environment and community metabolism, exploring growth-diversity
tradeoffs, quantifying metabolite crossfeeding relationships, relating metabolism and
disease states, and rationalizing patient-to-patient variability [75, 76]. Our model-
ing framework exploits the availability of 16S rDNA sequencing data to identify the
dominant genera present in the host-associated infection, the AGORA database [77]
to select a genome-scale metabolic reconstruction for a representative species from
each genera, and the SteadyCom method is used to simulate the community. We
have applied the in silico methods to a 20 species model of commensal species in
the human gut [75] and to a 17 species model including dominant pathogens of the
adult cystic fibrosis lung [76]. We have used this framework to study the interspecies
interactions between chronic wound microbiota comprising of 12 species.
Most naturally occurring microbial consortia exist in spatially heterogeneous en-
vironments that also exhibit temporal variations. The presence of spatial hetero-
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geneity plays an essential role in the evolution and function of microbial species
[78–82] and has profound effects on biofilm formation and development [4, 69, 83, 84].
Concentration gradients in key nutrients due to limited diffusion establish metabolic
niches within the biofilm that can produce spatial variations in biomass density [85]
and additionally spatial partitioning of species in the case of multispecies biofilms
[84, 86]. Quantitative understanding of the relationships between spatial and tempo-
ral variations in the extracellular environment and community metabolism is critical
to systematically analyze and rationally manipulate biofilm consortia. While spa-
tiotemporal metabolic models that account for both spatial and temporal variations
in the extracellular environment have been constructed, these models rely on table
lookups of precomputed flux balance solutions [87–89] or lattice based descriptions of
nutrient diffusion [90, 91].
The second approach considers heterogeneity in the system based on spatial and
temporal variations in the available nutrients. This methodology is based on combin-
ing genome-scale reconstructions with fundamental transport equations that capture
the relevant convective [92] and/or diffusional [93] processes. We applied this method-
ology to develop biofilm metabolic models that predict the complex spatiotemporal
behavior of multispecies systems associated with chronic wounds, hot lake microbial
mats and Clostridium difficile infections. The modeling framework helped to under-
stand the spatial arrangements of the species in the biofilm based on nutrient niches.
1.4 Thesis organization
The modeling frameworks developed in this thesis have been used in following
studies:
1. Chen, Jin, Jose A. Gomez, Kai Höffner, Poonam Phalak, Paul I. Barton, and
Michael A. Henson. “Spatiotemporal modeling of microbial metabolism.” BMC
systems biology 10, no. 1 (2016): 21.
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2. Phalak, Poonam, Jin Chen, Ross P. Carlson, and Michael A. Henson. “Metabolic
modeling of a chronic wound biofilm consortium predicts spatial partitioning of
bacterial species.” BMC systems biology 10, no. 1 (2016): 90.
3. Henson, Michael, and Poonam Phalak. “Byproduct cross feeding and com-
munity stability in an in silico biofilm model of the gut microbiome.” Processes
5, no. 1 (2017): 13.
4. Henson, Michael A., and Poonam Phalak. "Microbiota dysbiosis in inflam-
matory bowel diseases: in silico investigation of the oxygen hypothesis." BMC
systems biology 11, no. 1 (2017): 145.
5. Carlson, Ross P., Ashley E. Beck, Poonam Phalak, Matthew W. Fields,
Tomas Gedeon, Luke Hanley, William R. Harcombe, Michael A. Henson, and
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tributes to overflow metabolisms and emergent properties in cross-feeding mi-
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microbiota.” PLoS computational biology 14, no. 10 (2018): e1006558.
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(2019): 97.
8. Henson, Michael A., Giulia Orazi, Poonam Phalak, and George O’Toole.
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9. Phalak, Poonam, and Michael A. Henson. “Metabolic Modeling of Chronic
Wound Microbiota Predicts Mutualistic Interactions that Drive Community
Composition.” submitted.
10. Phalak, Poonam, Hans C. Bernstein, Stephen R. Lindemann, Ryan S. Renslow,
Dennis G. Thomas, Michael A. Henson and Hyun-Seob Song. “Modeling of
Spatiotemporal Metabolic Interactions in Autotroph-Heterotroph Consortia.”
in preparation.
This thesis comprises of detailed description of the biofilm metabolic modeling
of chronic wounds, C. difficile infections and environmental biofilms. In chapter 2,
the general biofilm modeling framework is described and it is applied to study two
species biofilms associated with chronic wounds. Various interactions between the
considered species are modeled. The model predicted the spatial partitioning and
maximum possible biofilm thicknesses based on these interactions. In chapter 3,
the developed biofilm framework is extended to study the interspecies interactions
between a photoautotroph and heterotroph community. The core metabolic models
for considered autotrophs and pan-genome model for heterotrophs are developed using
KBase. The biofilm model is validated by using experimental data. This model is used
to study interspecies interactions under extreme environmental conditions. In chapter
4, the biofilm modeling framework is extended to study the biofilms associated with
C. difficile infections. The biofilm model consisted of 3 species representing three
most common phyla and the pathogen C. difficile. This model is used to analyze
the healthy vs dysbiosis gut conditions during C. difficile infections. In chapter 5,
chronic wound community comprising of 12 most abundant species is studied. This
modeling framework is used to find out mutualistic relationships within the pathogens
and between pathogen and commensal species.
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CHAPTER 2
METABOLIC MODELING OF A CHRONIC WOUND
BIOFILM CONSORTIUM PREDICTS SPATIAL
PARTITIONING OF BACTERIAL SPECIES
2.1 Introduction
The aerobe Pseudomonas aeruginosa and the facultative anaerobe Staphylococ-
cus aureus are two bacteria commonly isolated from chronic wound biofilm infections
[56, 60, 65]. The same two bacteria are often key contributors to multispecies infec-
tions that occur in the lung mucous of cystic fibrosis patients [94]. P. aeruginosa
is known to exhibit much lower growth rates than S. aureus and other facultative
anaerobes in anaerobic environments common in chronic wound and mucoid biofilms
[95, 96]. Perhaps partially in response to this metabolic disadvantage, P. aeruginosa
has evolved a number of mechanisms to enhance its competitiveness in multispecies
biofilm communities.
The most widely studied mechanism is growth inhibition and lysis of competing
bacteria through the secretion of an arsenal of small molecule (e.g. pyocyanin [97])
and protein (e.g. bacteriocins [98]) toxins. The consumption of metabolic byproducts
secreted by other bacteria through cross feeding mechanisms also has been proposed
to enhance P. aeruginosa competitiveness [99]. Another putative mechanism is P.
aeruginosa chemotaxis towards high oxygen niches (i.e. aerotaxis [100]) where it is
metabolically competitive.
This work is published as: Phalak, Poonam, Jin Chen, Ross P. Carlson, and Michael A. Henson.
“Metabolic modeling of a chronic wound biofilm consortium predicts spatial partitioning of bacterial
species.” BMC systems biology 10, no. 1 (2016): 90.
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The biofilm models were formulated for P. aeruginosa and/or S. aureus metabolism.
We developed an effective computational method for solving the biofilm models, which
consisted of a set of partial differential equations with mixed boundary conditions
constrained by embedded linear programs. The models were used to analyze the
metabolic differences between single species and two species chronic wound biofilms
and to investigate putative factors that could impact the physiology of the two species
biofilm, including nutrient diffusion, metabolite cross-feeding, P. aeruginosa motility
and P. aeruginosa mediated lysis of S. aureus.
2.2 Multispecies biofilm model
2.2.1 Model formulation
Biofilm models were formulated by combining genome-scale reconstructions of P.
aeruginosa and/or S. aureus metabolism with uptake kinetics for available nutrients
and reaction-diffusion type equations for species biomass, supplied substrates and
synthesized metabolic byproducts. Single species biofilm models were formulated
with either the P. aeruginosa or S. aureus reconstruction, while the two species model
used both reconstructions. Diffusion was assumed to occur only in the axial direction
of the biofilm such that spatial variations could be captured with a single variable z
(Figure 2.1 A). For simplicity, the biofilm was assumed to have a fixed thickness W
over which the nutrients diffused and cell growth occurred. Therefore, the models were
most appropriate for predicting the metabolism of biofilms of a specified thickness.
Both strains were assumed to consume glucose as the primary carbon source [101].
Glucose was supplied at the tissue-biofilm interface at the assumed concentration
of the wound exudate, while oxygen was supplied at the biofilm-air interface at a
concentration for an aqueous solution in equilibrium with atmospheric oxygen.
The P. aeruginosa PA01 iMO1056 reconstruction accounts for 1,056 genes, 1,030
enzymes, 833 intracellular reactions and 277 exchange reactions [102]. This recon-
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Figure 2.1: Formulation and solution of the multispecies biofilm metabolic model. (A)
Schematic representation of the chronic wound biofilm model of constant thickness
W with glucose provided at the tissue-biofilm interface (z = 0), oxygen supplied at
the biofilm-air interface (z = W ) and the metabolic byproducts acetate, succinate
and lactate removed at the tissue-biofilm interface. (B) Schematic representation of
the biofilm metabolic model solution procedure.
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struction has been shown to provide good agreement with experimentally determined
biomass yields for aerobic growth on glucose and anaerobic growth on glucose with
nitrate as an electron acceptor. The preliminary flux balance calculations with a
maximum growth objective showed the primary metabolic byproducts to be acetate
and L-alanine. The secretion fluxes of other minor byproducts were approximately
an order of magnitude less than for acetate and L-alanine. P. aeruginosa is known to
secrete acetate, lactate and succinate [103], while the secretion of L-alanine has not
been reported. To obtain byproduct distributions in better agreement with reference
[103], we constrained the L-alanine secretion flux to zero. This modification resulted
in a redirection of flux from L-alanine to succinate with little effect on the secretion
fluxes of acetate and minor byproducts. Furthermore, we enforced a minimal non-
growth associated ATP maintenance flux of 5 mmol/gDW/h, the same value as in
the S. aureus reconstruction, to reduce the P. aeruginosa anaerobic growth rate for
consistency with experimental studies [95]. The iMO1056 reconstruction contained
succinate, lactate and acetate uptake fluxes that allowed the investigation of putative
cross feeding of metabolic byproducts. Secretion of the small molecule inhibitor py-
coyanin was included by adding an exchange flux with an adjustable lower bound that
forced pycoyanin synthesis, which was in opposition to growth rate maximization.
The S. aureus N315 iMH551 reconstruction accounts for 551 genes, 604 enzymes,
682 intracellular reactions and 92 exchange reactions [104]. This model correctly
reproduces byproduct secretion patterns under aerobic conditions with glucose limi-
tation and under anaerobic conditions with glucose excess [105–109]. The flux calcu-
lations showed that the primary byproducts were acetate and lactate. The iMH551
reconstruction contained lactate and acetate uptake fluxes that allowed reassimilation
of secreted metabolic byproducts. To explore the possibility of succinate cross feed-
ing, the S. aureus model was modified to allow succinate uptake through a putative
proton dependent symport mechanism.
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Uptake kinetics were specified for the supplied substrates glucose and oxygen as
well as for the possible cross-fed metabolites lactate, succinate and acetate. Although
both P. aeruginosa and S. aureus are well known for their ability to perform anaerobic
respiration using nitrate as an electron acceptor in place of oxygen, we have neglected
the possible role of denitrification in this study. Uptake kinetics were assumed to





where vi is the uptake rate (mmol/gDW/h) of the i-th substrate, Si is the extra-
cellular concentration (mmol/SL) of the i-th substrate, vmax,i is the maximum uptake
rate and Km,i is the half saturation constant. Equation (2.1) was used to establish
transport bounds on the uptake rates with the actual uptake rates being determined
by solution of the intracellular flux balance problem. Both vmax,i and Km,i were im-
portant parameters due to the large nutrient spatial gradients induced by diffusion
through the biofilm.






























− kdY Y − kLPY (2.3)
∂Y (0, t)
∂z
= 0 , ∂Y (W, t)
∂z
= 0
where X and Y are the biomass concentrations (g/L) of P. aeruginosa and S.
aureus, respectively, Z = X+Y is the total biomass concentration, and µX and µY are
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the corresponding growth rates (h−1) obtained from the flux balance calculations. If
local nutrient concentrations became too small to meet the ATP maintenance demand
of a species, then the flux balance problem for the species became infeasible at that
location. Once an infeasibility was detected, the death rate constant kdX or kdY
was exponentially increased from zero to a fixed, non-zero value to simulate that the
species would begin to die at that location. This approach ensured that the model
equations remained smooth and could be integrated. P. aeruginosa has flagella for
motility and can aerotaxis towards higher oxygen levels [100]. This capability was
captured in the model by including a typical chemotaxis term [110] where O is the
oxygen concentration (mmol/L) and kA is the aerotaxis rate constant. Cell growth
was restricted to a maximum cell concentration Zmax to account for cell crowding
effects within the biofilm. No flux boundary conditions were imposed at the tissue-
biofilm (z = 0) and biofilm-air (z = W ) interfaces under the assumption that cells
could not leave the biofilm via mechanisms such as dispersal.
P. aeruginosa secretes pyocyanin and other small molecules that are known to
inhibit and lyse of competing bacteria such as S. aureus [111]. This lysis mechanism
was included in the model through a pyocyanin concentration (P , mmol/L) dependent
death term with rate constant kL in the S. aureus mass balance in Equation (2.3).
Pyocyanin synthesis by P. aeruginosa and diffusion through the biofilm was captured














where vP is the specific pyocyanin synthesis rate obtained from the flux balance
calculation and DP is the pyocyanin diffusion coefficient. A no flux boundary condi-
tion was imposed at the biofilm-air interface assuming that the pyocyanin was non-
volatile. By contrast, a Robin boundary condition was imposed at the tissue-biofilm
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interface to describe possibly mass transfer limited removal of pyocyanin, where km,P
is pyocyanin mass transfer coefficient and Pb is the bulk pyocyanin concentration in
the tissue.
The glucose and oxygen mass balances were formulated under the assumptions
that oxygen gas-liquid mass transfer was fast compared to oxygen uptake and that
metabolites had negligible volatilities:
∂G(z, t)
∂t



















= 0 , DO
∂O(W, t)
∂z
= kmO[Ob −O(W, t)]
where G is the glucose concentration (mmol/L), the P. aeruginosa uptake fluxes
vGX and vOX and the S. aureus uptake fluxes vGY and vOY were obtained from
the flux balance calculations, and DG and DO are the glucose and oxygen diffusion
coefficients. For glucose, a no flux boundary condition was imposed at the biofilm-air
interface assuming glucose was not volatile and a Robin type boundary condition
was imposed at the tissue-biofilm interface to model possibly mass transfer limited
transport of glucose into the biofilm. Here kmG is the glucose mass transfer coefficient
and Gb is the bulk glucose concentration in the wound exudate. For oxygen, Robin
type boundary conditions were imposed at both interfaces with oxygen mass transfer
coefficient kmO, oxygen concentration Ob at the tissue-biofilm interface and oxygen
concentration Oa at the biofilm-air interface.















where Mj is concentration (mmol/L) of the j-th byproduct (A = acetate, S =
succinate, L = lactate), the secretion/consumption fluxes vMJ X and vMJ Y were ob-
tained from the flux balance calculations and DMj is the diffusion coefficient. No
flux boundary conditions were imposed at the biofilm-air interface, while Robin type
boundary conditions were imposed at the tissue-biofilm interface to allow removal of
the byproducts. All biofilm diffusion coefficients were assumed to depend on the total
biomass concentration Z such that diffusion was reduced in more dense regions of the
biofilm [112].
2.2.2 Model parameters
We found a dearth of literature for determining species specific values for the 20
parameters needed to calculate uptake rates with respect to the five possible nutrients
(glucose, oxygen, succinate, lactate, acetate). Consequently, the two species were
assumed to have the same uptake parameter values. We used representative glucose
[113, 114] and oxygen [114, 115] uptake parameter values reported for the model
bacterium Escherichia coli under the assumption that P. aeruginosa and S. aureus
should have similar values. Because we were not able to find reliable uptake parameter
values for succinate, lactate and acetate, the associated vmax and Km values were
assumed to be equal to those for glucose (Table 2.1). Therefore, results focused on
differences in metabolic network structure of the two species and not on differences
in uptake properties.
Other parameter values for the biofilm model were obtained from the literature
to the extent possible (Table 2.2). We utilized a typical biofilm thickness W=80µm
and assumed wound exudate concentrations consistent with published values. The
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Table 2.1: Nominal nutrient uptake parameters
Nutrient vmax km
Glucose 10 mmol/gDW/h 0.5 mmol/L
Oxygen 20 mmol/gDW/h 0.003 mmol/L
Succinate 10 mmol/gDW/h 0.5 mmol/L
Lactate 10 mmol/gDW/h 0.5 mmol/L
Acetate 10 mmol/gDW/h 0.5 mmol/L
air oxygen concentration Oa was derived from the oxygen content of atmospheric air.
P. aeruginosa and S. aureus cell death were implemented by exponentially increasing
the death rate constants from zero to the values listed in Table 2.2 when local
nutrient concentrations were not sufficient to meet ATP maintenance demands. The
lower bound on the P. aeruginosa pyocyanin synthesis flux vP,min was tuned such
that the average pyocyanin concentration within the biofilm was the same order of
magnitude as that observed experimentally in [116]. The S. aureus inhibitor-mediated
death constant kL was tuned to achieve reasonable spatial distributions of the two
species, which included P. aeruginosa dominance in the aerobic region of the biofilm,
S. aureus dominance in the anaerobic region and a sharp spatial division between the
two species [86, 117–119].
The maximum achievable biomass concentration Zmax was chosen to be within the
large range of published values [85]. We established reasonable metabolite concen-
trations within the biofilm by adjusting a single mass transfer coefficient for glucose,
acetate, succinate, lactate and pyocyanin such that their average concentrations were
the same order of magnitude as those observed experimentally in [116] and [120] .
The P. aeruginosa aerotaxis rate constant kA was chosen such that P. aeruginosa
was dominant in the aerobic region of the biofilm and a sharp spatial division be-
tween the two species was established as the biofilm matured towards a steady-state
condition [82, 86, 124]. Initial conditions for each simulation were generated by first
running a simulation with each species biomass concentration constrained to be 1 g/L
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Table 2.2: Nominal model parameter values
Parameter Description Value Reference
W Biofilm thickness 80 µm Specified
Gb Bulk glucose concentration 7.5 mmol/L [120]
Oa O2 conc. at the biofilm-air inter-
face
0.21 mmol/L [121]
Ob O2 conc. at the tissue-biofilm in-
terface
0 mmol/L Specified
Sb Bulk succinate concentration 0 mmol/L Specified
Ab Bulk acetate concentration 0 mmol/L Specified
Lb Bulk lactate concentration 1 mmol/L [120]
Pb Bulk pyocyanin concentration 0 mmol/L Specified
kdX , kdY Death rate constants 0-0.01 h−1 Calculated
kL Pyocyanin-associated death rate
constant
0.4 mmol/gDW/h Specified
kdP Pyocyanin flux bound 0.1 L/mmol/h Specified
Zmax Maximum biomass concentration 200 g/L [85]
X0, Y0 Initial biomass concentrations 1 g/L Specified
kA Aerotaxis rate constant 5 x10−8 cm2. L/mmol. s Specified
DG Aq. diffusion coefficient for glu-
cose
9.4x10−6 cm2/s [122]
DO Aq. diffusion coefficient for oxy-
gen
26.8x10−6 cm2/s [122]
DA Aq. diffusion coefficient for ac-
etate
16.2x10−6 cm2/s [122]
DS Aq. diffusion coefficient for succi-
nate
12.6x10−6 cm2/s [122]
DL Aq. diffusion coefficient for lac-
tate
12.1x10−6 cm2/s [123]
DP Aq. diffusion coefficient for py-
ocyanin
7.2x10−6 cm2/s Specified
km,i Mass transfer coefficient 2x10−4 cm/s Specified
km,O Oxygen mass transfer coefficient 2x10−2 cm/s Specified
and capturing the resulting steady-state solution. These initial conditions reflected a
newly developed, nearly spatially homogeneous biofilm with small cell densities, high
nutrient levels and low byproduct concentrations.
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2.2.3 Model solution
The two species biofilm model consisted of a set of partial differential equations
(PDEs) with mixed boundary conditions and embedded linear programs (LPs). The
efficient and stable solution of such models is a challenging problem at the forefront
of microbial metabolic modeling [125]. As described in our previous publications
[92, 93], we pursued a spatial discretization approach based on converting the PDEs
into a large set of ordinary differential equations (ODEs) in time with embedded LPs
(Figure 2.1 B). The spatial domain [0, W ] was discretized using N = 50 node points
at which the diffusion terms in Equations (2) - (7) were discretized using central
difference approximations with second-order accuracy. The specified boundary con-
ditions were incorporated into the central difference approximations at the boundary
node points. This procedure yielded a set of 8 ODEs at each node point for the lo-
cal concentrations of P. aeruginosa and S. aureus biomass, glucose, oxygen, acetate,
succinate, lactate and pyocyanin.
This ODE system was solved using DFBAlab [126], a MATLAB tool that explicitly
addresses problems associated with LP alternative optima and possible infeasibilities
[127]. DFBAlab employs a lexicographic optimization strategy in which a series of
LP problems are sequentially solved to ensure the determination of unique exchange
fluxes necessary for a well-defined dynamic system. Each LP is solved subject to
constraints that the previous objectives are equal to their optimal values, with the
required number of LPs equal to the number of exchange fluxes. We specified the
lexicographic optimization objectives to reflect known or anticipated physiology of the
two species biofilm community (Table 2.3). We found that reordering these objectives
had no noticeable effect on simulation results. Each node point was represented by 8
ODEs for the local species and metabolite concentrations and 12 LPs for lexicographic
optimization. We employed 50 node points such that the discretized biofilm model
consisted of 400 ODEs and 600 LPs.
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Table 2.3: Lexicographic optimization.
Species Number Direction Objective
P. aeruginosa 1 Maximize Growth rate
P. aeruginosa 2 Minimize Acetate secretion
P. aeruginosa 3 Minimize Succinate secretion
P. aeruginosa 4 Maximize Glucose uptake
P. aeruginosa 5 Maximize Oxygen uptake
P. aeruginosa 6 Maximize Lactate uptake
S. aureus 1 Maximize Growth rate
S. aureus 2 Minimize Acetate secretion
S. aureus 3 Minimize Lactate secretion
S. aureus 4 Maximize Glucose uptake
S. aureus 5 Maximize Oxygen uptake
S. aureus 6 Maximize Succinate uptake
All simulations were performed with MATLAB 8.5 (R2015a) using DFBAlab,
the stiff MATLAB integrator ode15s for dynamic flux balance model solution and
Gurobi 6.0 for linear program solution. A typical 1000-hour dynamic simulation
for determining a steady-state solution required about 25 minutes running on an
ASUS computer with Intel Core i7-960 processor and 24 GB RAM. As compared to
alternative computational methods for spatiotemporal metabolic modeling based on
table lookups of precomputed FBA solutions combined with integration of the PDEs
on a coarse spatial grid [87–89] and real-time FBA solution combined with lattice-
based descriptions of metabolite diffusion [90, 91], we believe our approach offers
several important advantages including the use of DFBAlab, the ability to directly
embed LPs within the discretized ODEs, and the flexibility to solve the ODE-LP
system using stiff integrators with variable step size and error control.
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2.3 Results and discussion
2.3.1 Metabolism of single species and multispecies biofilms
We first performed simulations for single species biofilms consisting of only P.
aeruginosa or S. aureus. Initial conditions were chosen to reflect a nearly spatially
homogeneous biofilm with low cell densities X(z, 0) = 1 g/L or Y (z, 0) = 1 g/L.
For each species, biofilms of different thicknesses were simulated to determine the
maximum thickness Wmax that could be sustained according to the model. If the
biomass concentration was below 10 g/L (5% of the maximum value Zmax = 200 g/L)
anywhere in the mature biofilm obtained after 1000 hours of simulation, the thickness
was deemed too large and reduced. These simulations revealed that S. aureus could
grow much thicker biofilms with Wmax = 90 µm compared to P. aeruginosa with
Wmax = 30 µm, mainly due to superior S. aureus anaerobic growth rates.
Dynamic simulations were performed for two species biofilms consisting of P.
aeruginosa and S. aureus using eight different hypothetical scenarios. Scenario 1 was
the base case where the two bacteria competed for glucose and oxygen in the absence
of byproduct crossfeeding, P. aeruginosa aerotaxis or pyocyanin-mediated lysis of S.
aureus. We found the two species Wmax = 80 µm, which was slightly less that the
S. aureus Wmax = 90 µm but substantially larger than the P. aeruginosa Wmax = 30
µm. The two speciesWmax was a linear combination of the single speciesWmax values
weighted by the average biomass concentrations in the two species biofilm.
When the two species biofilm thickness was set equal to Wmax = 80 µm, pseudo
steady-state solutions were obtained after only 50 hours of simulation (Figure 2.2A).
These results are in-line with many experimental studies [128, 129]. Oxygen was
quickly depleted throughout most of the biofilm, except near the biofilm-air interface
where an aerobic region was established as observed experimentally [130]. Similarly,
glucose was rapidly depleted in all regions except near the tissue-biofilm interface
where a glucose rich region was maintained. S. aureus was predicted to quickly estab-
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Figure 2.2: Predictions for a two species biofilm of thickness W = 80 µm (Base case
scenario). (a) Time resolved predictions over the first 50 hours at the bottom, middle
and top of the biofilm. (b) Spatially resolved biomass and metabolite concentration
predictions after 1000 hours. (c) Spatially resolved effective growth and uptake rate
predictions after 10 hours.
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lish dominance throughout the biofilm due to its higher local growth rates, especially
in the anaerobic region. Initially acetate and succinate levels increased but there-
after they were predicted to decrease due to metabolite removal at the tissue-biofilm
boundary. Lactate levels were predicted to remain high throughout the biofilm due to
S. aureus synthesis in the anaerobic region and diffusion into the aerobic region. Mul-
tispecies biofilm spatial profiles obtained after 1000 hours of simulation (Figure 2.2)
were characterized by the presence of a glucose rich, anaerobic region near the tissue-
biofilm interface and a glucose depleted, aerobic region near the biofilm-air interface.
S. aureus was predicted to be dominant throughout the biofilm, especially in the
anaerobic region, while P. aeruginosa was predicted to be present only in the aerobic
region. Byproduct profiles were similar to those obtained for the S. aureus single
species biofilm (not shown here) with high lactate levels, low acetate levels and no
succinate production. We attributed this behavior to partitioning of P. aeruginosa to
the aerobic region where the synthesis of byproducts was substantially reduced. These
model predictions could be experimentally tested by measuring metabolite concen-
tration profiles using spatially resolved metabolomics [131–133] and gene expression
profiles using spatially revolved transcriptomics [134, 135].
To further analyze how multispecies metabolism depended on position in the
biofilm, local effective growth rates and nutrient uptake rates were determined from
the base case (BC) simulation data. For species i, the local effective growth rate was
calculated as the difference between the biomass restricted growth rate µi(1−Zi/Zmax)
and the energy associated death rate kdi at a given position z. Consequently, the ef-
fective growth rate could be negative in nutrient lean regions. The calculations were
performed using data collected at t = 10 hours because these initial rates offered in-
sights into biofilm physiology. S. aureus growth rates exceeded P. aeruginosa growth
rates at all positions, especially in the anaerobic region near the bottom of the biofilm
where P. aeruginosa death was predicted (Figure 2.2C). Both species were predicted
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to have constant growth rates in the upper aerobic region. The P. aeruginosa growth
rate decreased rapidly in the lower half due to decreasing oxygen availability such that
death occurred in the first 35 µm. By contrast, the S. aureus growth rate increased
rapidly in this region due to the increasing availability of glucose to support anaerobic
growth. As time progressed, these local growth rates resulted in S. aureus dominance
throughout the biofilm and P. aeruginosa presence only in the aerobic region (Fig-
ure 2.2B). The glucose uptake rate increased monotonically from bottom to top of the
biofilm, while the oxygen uptake rate was predicted to exhibit a maximum near the
center because that location offered the optimal combined availability of glucose and
oxygen to support consortium growth. The experimental determination of spatially
resolved biomass concentrations [136] would be beneficial in this context.
2.3.2 Byproduct cross feeding
Cross feeding of secreted metabolic byproducts is common in bacterial commu-
nities [137, 138] and multispecies biofilms [139, 140]. For example, a cross feeding
mechanism has been proposed for a polymicrobial infection system consisting of the
two facultative anaerobes Aggregatibacter actinomycetemcomitans and Streptococcus
gordonii [139]. We hypothesized that cross feeding of secreted metabolic byproducts
(lactate, succinate, acetate) would enhance the competitiveness of P. aeruginosa in
the aerobic portion of the biofilm. Except for the inability of S. aureus to consume
acetate, experimental studies as well as our previously reported FBA results [141]
show that the two species are capable of metabolizing these byproducts in the pres-
ence of sufficient oxygen. Therefore, we investigated the impact of putative cross
feeding by allowing each species to enhance its growth through uptake of the three
byproducts (C-f scenario). The two species were assumed to uptake each byproduct
with the same kinetics (see Table 2.2) due to lack of data on species and substrate
specific uptake parameters.
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Figure 2.3: Predictions after 1000 hours for two species biofilms of thickness W =
80 µm with different species interaction mechanisms. (a)(A-D) Spatially resolved
biomass concentrations and (E) P. aeruginosa (Pa), S. aureus (Sa), total biomass
concentrations averaged across the biofilm and maximum thickness for the eight con-
sidered scenarios.
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The cross-feed scenario model predicted thatWmax remained 80 µm when byprod-
uct cross feeding was incorporated. Because glucose was the more energetically favor-
able carbon source, most of the available oxygen was used for glucose oxidation and
little oxygen remained for lactate oxidation. Contrary to our hypothesis, cross-feeding
reduced the region where P. aeruginosa was present and did not substantially increase
the P. aeruginosa biomass concentration within this region (Figure 2.3, panel A). To
succinctly quantify this behavior, the P. aeruginosa and S. aureus biomass concen-
trations were averaged across the biofilm and compared to average concentrations
obtained for the base case scenario without cross feeding. While the total biomass
concentration was not affected, cross-feeding increased the fraction of S. aureus rela-
tive to P. aeruginosa (Figure 2.3E). Since lactate was the primary byproduct of the
two species biofilm, we attributed this behavior to S. aureus having more efficient
lactate metabolism. Previously reported single species FBA results showed that S.
aureus had higher growth rates on lactate under oxygen sufficient and oxygen lim-
ited conditions [141]. Because similar behavior was observed for glucose metabolism
in single species biofilms, the addition of lactate consumption was predicted to fur-
ther increased S. aureus dominance in the aerobic region where sufficient oxygen was
available for lactate oxidation.
Byproduct cross feeding in P. aeruginosa/S. aureus chronic wound biofilms has
not been experimentally studied to our knowledge and represents a promising area
of research. Experimental studies with P. aeruginosa biofilms in the cystic fibrosis
lung show that lactate actually can be a preferred carbon source to glucose [142,
143], suggesting enhanced lactate uptake capabilities. This environmental dependence
emphasizes the importance of conducting uptake experiments and studying cross
feeding under chronic wound relevant conditions. Well controlled planktonic growth
experiments are needed to accurately estimate ATP maintenance demands of the two
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species, since lactate oxidation might confer a growth advantage to P. aeruginosa if
the energetics are more favorable than those modeled.
2.3.3 P. aeruginosa inhibition of S. aureus
P. aeruginosa secretes a wide variety of inhibitory compounds that have been
shown to enhance its competitiveness against competing bacteria in multispecies
biofilm communities [144–146]. P. aeruginosa is known to secrete pyocyanin which
inhibit and lyse competing bacteria such as S. aureus. Additional simulations were
performed to explore the impact of a putative pyocyanin-mediated lysis mechanism
on the two species biofilm. When this mechanism was combined with nutrient compe-
tition (Ly scenario), the model predicted that Wmax was slightly increased to 90 µm.
Reduction of S. aureus biomass in the anaerobic region resulted in slightly higher
glucose levels throughout the biofilm, allowing increased P. aeruginosa growth in the
upper aerobic region and a greater biofilm thickness.
To allow direct comparison with the other species interaction scenarios, simula-
tions also were performed for an 80 µm thick biofilm. Spatial profiles showed sharp
partitioning of the two species with P. aeruginosa dominant in the upper aerobic
region of the biofilm (Figure 2.3, panel C). This effect was achieved at the expense
of the S. aureus biomass concentration, which was substantially reduced in the lower
anaerobic region and dropped to zero at 40 µm.
The metabolic burden of synthesizing pyocyanin was predicted to have a minimal
effect on P. aeruginosa growth due to the small enforced bound of 0.1 mmol/gDW/h.
At a maximum glucose uptake rate of 10 mmol/gDW/h, only 2.2% of available carbon
was used for pyocyanin synthesis. While we tuned our model to obtain reasonable
extracellular pyocyanin concentrations [117], key parameters (i.e. synthesis rate, dif-
fusion coefficient, killing rate) associated with the mechanism are unknown and need
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to be experimentally determined to accurately quantify the effect in chronic wound
environments.
Combining byproduct cross feeding and the lysis mechanism (Ly+C-f scenario) did
not changeWmax from the pyocyanin-free case (C-f scenario) but did increase S. aureus
competitiveness by shifting the location where the species partitioned approximately
15 µm towards the biofilm-air interface (Figure 2.3, panel B). The addition of cross
feeding resulted in average biomass concentrations that were roughly equal, while total
biomass was reduced (Figure 2.3E). We hypothesized that this unexpected effect was
due to increased oxygen utilization by S. aureus for lactate oxidation. Although S.
aureus biomass was simultaneously reduced by pyocyanin- mediated lysis, the oxygen
used for S. aureus growth was not available for P. aeruginosa oxidative growth and
total biomass decreased. Therefore, the pyocyanin mechanism was interpreted as an
antagonistic mechanism by which P. aeruginosa increased its own competitiveness.
2.3.4 P. aeruginosa aerotaxis
P. aeruginosa has a single flagellum that may allow motility in complex, hetero-
geneous environments such as biofilms [147] while S. aureus is generally viewed as
non-motile [148]. More specifically, P. aeruginosa has been observed to chemotax
towards higher oxygen environments, a process known as aerotaxis, which offer more
favorable growth conditions [100]. To explore the impact of this putative aerotaxis
mechanism on two species biofilm metabolism, the P. aeruginosa biomass equation
included a chemotaxis term (see Equation 2.2) and simulations were performed with
both nutrient competition and aerotaxis (AT scenario). The energy requirements for
chemotaxis were assumed negligible compared to growth. When aerotaxis was com-
bined with nutrient competition, the model predicted thatWmax was increased to 120
µm and nearly complete species partitioning as observed experimentally [86, 149],
with P. aeruginosa dominant in the upper aerobic half and only S. aureus present
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in the lower anaerobic region. Aerotaxis increased spatial partitioning of the two
species (see Figure 2.3, panel C) such that P. aeruginosa had access to more oxygen
for lactate respiration, resulting in a thicker biofilm.
Spatial profiles generated for an 80 µm biofilm show almost complete partition-
ing of the two species, with P. aeruginosa dominating in the upper aerobic half,
only S. aureus present in the lower anaerobic region, and the two species coexist-
ing for about 10 µm near the middle of the biofilm (Figure 2.3, panel C). Aerotaxis
allowed P. aeruginosa to substantially improve its competitiveness by increasing its
concentration in the upper portion of the biofilm rather than by moving the tran-
sition region between the two species (see Figure 2.2B). When averaged across the
biofilm, the biomass concentrations of the two species were approximately equal while
total biomass was unaffected compared to the aerotaxis-free case (Figure 2.3E). Un-
like pyocyanin-mediated lysis, aerotaxis can be viewed as an antagonistic mechanism
by which P. aeruginosa increased its own competitiveness without reducing total
cell densities. Biofilm reactor experiments aimed at demonstrating and quantifying
the aerotactic response would be highly beneficial. Experimental testing could be
achieved through a combination of traditional and spatially resolved omics technolo-
gies [133, 134, 150].
When byproduct cross feeding was added to P. aeruginosa aerotaxis and nutri-
ent competition (AT+C-f scenario), the model predicted Wmax = 120 µm, the same
value obtained in the absence of cross feeding. When simulations were performed
for an 80 µm thick biofilm, the addition of cross feeding substantially increased S.
aureus biomass in the biofilm while having a small negative impact on total biomass
(Figure 2.3E). Of the eight scenarios investigated, a maximum Wmax = 130 µm was
predicted when nutrient competition and aerotaxis were combined with pyocyanin-
mediated lysis of S. aureus (AT+Ly scenario). In this case, P. aeruginosa had access
to increased glucose due to S. aureus death in the anaerobic region and increased lac-
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tate due to the absence of S. aureus in the aerobic region, which combined to enhance
P. aeruginosa growth and allow a thicker biofilm. For a nominal biofilm thickness of
80 µm, only P. aeruginosa was present in the upper 50 µm of the biofilm and the
amount of S. aureus was relatively small in the lower anaerobic region (Figure 2.3,
panel D). The further addition of byproduct cross feeding did not affect Wmax but
did increase S. aureus competitiveness (AT+Ly+C-f scenario) (Figure 2.3E). Collec-
tively, these predictions suggest that both pyocyanin-mediated lysis and aerotaxis are
potentially powerful mechanisms for P. aeruginosa to enhance its competitiveness in
multispecies biofilms with the faster growing facultative anaerobe S. aureus.
2.4 Conclusions
Chronic wounds are often colonized by bacteria consortia growing as biofilms on
a complex mixture of wound exudate. Improved understanding of these complex
multispecies systems is required to develop more rational and effective antibiotic
therapies for biofilm eradication. We developed genome-scale spatiotemporal models
of a two species consortium comprised of the chronic wound isolates Pseudomonas
aeruginosa and Staphylococcus aureus to investigate the impact of putative species
interaction mechanisms on biofilm physiology. The models were used to analyze the
metabolic differences between single species and two species biofilms and to investigate
the impact of nutrient competition, byproduct cross feeding, P. aeruginosa inhibition
of S. aureus growth and P. aeruginosa aerotaxis on the relative abundance and spatial
distribution of each species. The key predictions of the computational modeling study
were:
• The two species system was predicted to support a maximum biofilm thickness
much greater than P. aeruginosa alone but slightly less than S. aureus alone,
suggesting an antagonistic metabolic effect of P. aeruginosa on S. aureus.
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• Nutrient gradients imposed by supplying glucose at the bottom and oxygen
at the top of the biofilm induced spatial partitioning of the two species, with
S. aureus most concentrated in the lower anaerobic region and P. aeruginosa
present only in the upper aerobic region.
• When each species was allowed to enhance its growth through consumption of
secreted metabolic byproducts assuming identical uptake kinetics, the compet-
itiveness of S. aureus was further enhanced due to its more efficient lactate
oxidative metabolism.
• Lysis of S. aureus by the small molecule inhibitor pyocyanin secreted from P.
aeruginosa and/or P. aeruginosa aerotaxis towards high oxygen levels were
predicted to enhance spatial portioning of the two species and to increase P.
aeruginosa competitiveness in the aerobic region.
These model predictions require further validation through the execution of tar-
geted experiments that augment existing results in the literature that support our
conclusions. P. aeruginosa lysis of S. aureus combined with nutrient competition is








The environmental communities play an important role in production and utiliza-
tion of organic matter, degradation of toxic compounds and the cycling of nitrogen,
sulfur and other metals [151, 152]. The interactions between the species in commu-
nity through exchanges of metabolites, scavenging of toxins shape the community
structure and abundances. It is very important to understand the interspecies inter-
actions to analyze and interpret the dynamics of community formation, the functional
relationships between these species and the complex metabolic processes within the
community. As a typical example, cyanobacteria and heterotrophic species in nature
form stable microbial mats or biofilms by developing synergistic relationships. The
cyanobacteria are photoautotrophs that convert inorganic matter with the help of
light energy into useful organic compounds and oxygen, which are then consumed by
the heterotrophic species in the vicinity [153]. Cyanobacteria also benefit from the
presence of their partners because heterotrophs produce carbon dioxide - a major car-
bon source for cyanobacteria - and remove the toxins that otherwise may inhibit the
growth of cyanobacteria. For controlling the dynamics of these communities, it is crit-
ical to understand how metabolic interactions between autotrophs and heterotrophs
occur and, how they are constrained in space and time, and how those constraints af-
fect community dynamics and biochemical function. Predictive mathematical models
such as community metabolic networks can serve as a useful tool for this purpose.
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Here, We would be using mathematical models to analyze and interpret the inter-
actions within this community. Mathematical simulation is a useful tool to evaluate
the growth and abundances of species in 3D biofilm spatial structures. The main
objective of this study is to develop a mathematical model to analyze the autotrophic
and heterotrophic growth, to account for interspecies interactions through metabolite
exchanges and to predict spatial arrangements of the species in the biofilm. The mul-
tispecies biofilm model will be validated by using experimental data available from
the study on photoautotroph-heterotroph biofilms [154]. The validated model will
be used to predict the important interactions for the community stability and devel-
opment of metabolic niche in the environment. The model will be a useful tool to
study various autotrophic-heterotrophic interactions. It will help to engineer the spe-
cific communities like biofuel producing communities, to analyze the biogeochemical
cycles in the nature and to understand the role of autotroph-heterotrophs in ecology.
3.2 Material and methods
3.2.1 System description
For model development, we chose microbial-mat-derived unicyanobacterial consor-
tia previously studied by [154]. in which the biofilms were grown in the tissue culture
flasks, the metabolomics, dry weight, composition, total protein and cell counts were
measured. This study concluded that two consortia had distinct species of cyanobac-
teria which were primary producers along with nearly identical heterotrophs present
in both the systems. The metabolomic study detected glucose in all the samples.
Inorganic carbon was the sole carbon source supplied to the consortia. The biofilms
were grown for 28 days under continuous photon flux of 35 µE/m2/s. The autotroph
and heterotroph biomass obtained from the published study are shown in Figure 3.1B
(UCCA) and Figure 3.1C (UCCO). The study concluded that UCCA produced higher
autotroph biomass as compared to UCCO.
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Figure 3.1: Formulation of the multispecies biofilm metabolic model. (A) Schematic
representation of the autotroph-heterotroph biofilm model of constant thickness L
with CO2, photon, O2, nitrate and phosphate provided at the L = 0 µm. (B) Exper-
imental UCC-A autotroph and heterotroph biomass concentration (g/L) plotted at
various locations in the biofilm at different time points. (C) Experimental UCC-O au-
totroph and heterotroph biomass concentration (g/L) plotted at various locations in
the biofilm at different time points. (D) Number of reactions, metabolites and genes
present in core metabolic network model of considered autotrophs and heterotroph.
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3.2.2 Model formulation
The multispecies biofilm model was constructed for autotroph and heterotroph
community in microbial mat derived unicyanobacterial consortia. The biofilm was
assumed to be formed on the flask surface as described in previous publication [154],
this interface was termed as bottom of the biofilm (L = 30µm) (Figure 3.1A). The
metabolites such as inorganic carbon in the form of CO2, O2, nitrate and phosphate
were supplied at the top of the biofilm (L = 0µm). The biofilm was assumed to be
growing under constant photon incidence rate supplied at top of the biofilm. The
autotrophs in the community were assumed to convert CO2 in presence of photon
energy to organic carbon (glucose) and oxygen which were consumed by heterotrophs
in the community. Heterotrophs generated CO2 as a metabolic byproduct which was
consumed by autotrophs in the community. Diffusion was assumed to occur only
in the axial direction of the biofilm such that spatial variations could be captured
with a single variable z (Figure 3.1A). For simplicity, the biofilm was assumed to
have a fixed thickness L over which the nutrients diffused, and cell growth occurred.
Therefore, the models were most appropriate for predicting the metabolism of biofilms
of a specified thickness.
The spatiotemporal models for photoautotroph-heterotroph consortia were con-
structed by combining core metabolic network models with nutrient uptake kinetics
and reaction-diffusion equations for species biomass, supplied substrates and synthe-
sizes metabolic byproducts.














where Xi was the biomass concentration (g/L) of i-th species. µi is the growth
rate (h−1) of the i-th species. The biomass was assumed to be diffused with diffusion
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coefficient (DXi) and removed from the both ends of the biofilm at the mass transfer
rates (kXi,0 and kXi,L).
The metabolite concentrations (CO2, phosphate, nitrate, glucose and oxygen)










= kmMj [Mj,b −Mj(0, t)] , −DMj
∂Mj(L, t)
∂z
= kmMj [0−Mj(L, t)]
where Mj was the concentration (mmol/L) of j-th metabolite (CO2, phosphate, ni-
trate, glucose, O2). The uptake fluxes vMjXi of j-th metabolite for i-th species was
calculated from flux balance calculations. The metabolites were assumed to be dif-
fused at the rate of DMj and removed from the bottom of the biofilm at the mass
transfer rate, km,Mj . Mj,b was bulk concentration of the metabolite at the air-biofilm
interface. We supplied CO2, phosphate, nitrate and O2 at the top of the biofilm and
the accumulated metabolites were removed from the bottom of the biofilm.
Uptake kinetics were specified for the four primary metabolites: CO2, photon,






where vi is the uptake rate (mmol/gDW/h) of the i-th substrate, Si is the extra-
cellular concentration (mmol/SL) of the i-th substrate, vmax,i is the maximum uptake
rate and Km,i is the half saturation constant. Equation (2.1) was used to establish
transport bounds on the uptake rates with the actual uptake rates being determined
by solution of the intracellular flux balance problem. Both vmax,i and Km,i were im-
portant parameters due to the large nutrient spatial gradients induced by diffusion
through the biofilm.
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where vp and vn are the uptake rates (mmol/gDW/h), P and N are the extra-
cellular concentrations (mmol/L), vmax,p and vmax,n are the maximum uptake rates
and Km,p and Km,n are the half saturation constants of the phosphate and nitrate
respectively. Equations (3.4 and 3.5) were used to establish transport bounds on
the uptake rates with the actual uptake rates being determined by solution of the
intracellular flux balance problem. The parameters αp and αn were added to evaluate
the effect of restricted phosphate and nitrate uptakes on biomass concentration and
species interactions.
The photon incidence rate was calculated by using Beer-Lambert law,
I = Iine−(ktot(L−z)) (3.6)
Where Iin is the initial photon incident rate (µE/m2s). The attenuation coefficient,
ktot was adjusted to achieve enough penetration of light into the biofilm. The photon
incidence rate obtained from this equation was used to calculate the lower bound on
photon uptake rate by using nutrient uptake kinetics. The lower bound of photon
uptake rate along with other nutrient bounds were used for solving core metabolic
model and the corresponding growth rates of autotrophs were obtained.
The core metabolic network models were obtained by supplying genomes of the
considered species to Kbase. Kbase platform was used to gapfill the core metabolic
network models. The autotrophic cyanobacterium Phormidesmis priestleyi ANA and
cyanobacterium Phormidium sp. OSCR core metabolic models were gapfilled us-
ing Kbase tool Gapfill Metabolic Model. The heterotroph model was generated by
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combining genomes of most abundant species in consortia Bin 01 (Bacteriodetes),
Bin18 (Rhodo), Bin10 (HL-49), Bin 04 (Plasmid), Bin 02 (HL-53) and Bin 05 (HL-
91) [155]. The autotroph-1 model accounts for 140 genes, 125 metabolites and 134
reactions whereas autotroph-2 model accounts for 124 genes, 137 metabolites and
139 reactions. The core scale metabolic networks for autotrophs have been shown
to provide good agreement with experimentally obtained biomass growth rates on
photon and CO2. Our preliminary flux balance calculations with maximum growth
objective showed that the autotroph produced glucose and oxygen as byproducts.
The heterotroph core metabolic model was examined for various glucose and oxygen
uptake rates and found to be in good agreement with experimental growth rates. The
major byproduct of heterotroph metabolism was CO2.
3.2.3 Solving model equations
The biofilm model was consisting of a set of partial differential equations (PDEs)
with mixed boundary conditions and embedded LPs. We converted those PDEs to or-
dinary differential equations (ODEs) by discretizing in space. The algebraic equation
(AE) for photon balance equation combined with the ODEs led to system of dif-
ferential algebraic equations (DAEs). The DAE system was solved using DFBAlab,
a MATLAB tool that explicitly addresses problems associated with LP alternative
optima and possible infeasibilities. DFBAlab employs a lexicographic optimization
strategy in which a series of LP problems are sequentially solved to ensure the de-
termination of unique exchange fluxes necessary for a well-defined dynamic system.
We specified the lexicographic optimization objectives to reflect the anticipated phys-
iology of the autotroph-heterotroph biofilm (Table 3.1. We used 30 spatial node
points to achieve fast and accurate solutions. We solved 210 ODEs, one 1 algebraic
equation for photon balance and 390 LPs in MATLAB 2017b using DFBAlab, stiff
ode integrator ode15s and Gurobi 7.5.2 as a LP solver [93, 141].
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Table 3.1: Lexicographic objective functions
Species Number Direction Objective
Autotroph 1 Maximize Growth rate
Autotroph 2 Minimize Glucose secretion
Autotroph 3 Minimize Oxygen secretion
Autotroph 4 Maximize CO2 uptake
Autotroph 5 Maximize Photon uptake
Autotroph 6 Maximize Nitrate uptake
Autotroph 7 Maximize Phosphate uptake
Heterotroph 1 Maximize Growth rate
Heterotroph 2 Maximize CO2 secretion
Heterotroph 3 Minimize Glucose uptake
Heterotroph 4 Maximize Oxygen uptake
Heterotroph 5 Maximize Phosphate uptake
3.2.4 Model parameters
For determining parameter values, we used the species abundance data available
at various depths in the biofilms of UCC-A and UCC-O at different times (see Figure
3.1B and 3.1C). The spatial data available for the fraction of biomass was converted
to the biomass concentration at various locations by using biofilm density. The con-
centration of autotrophs and heterotrophs vary in space and time. We used day 7
spatial data as an initial condition for the model and validated the model for day 14,
day 21 and day 28. We used least square curve (lscurvefit) fitting technique in MAT-
LAB to fit the experimental data and validate the biofilm model. The lower bound
and upper bounds on the parameters were chosen based on the available literature
values. The global optima were ensured by using multistart option in MATLAB.
This approach chose various starting points in from the lower and upper bounds.
The parameters used in the biofilm model are shown in Table 1. The kinetic pa-
rameters (vmax and Km) for the metabolites were obtained from model fitting. We
have used the values obtained from literature as the initial guesses for vmax and Km
[114, 156, 157]. The aqueous diffusion coefficients for substrates and byproducts were
converted to the biofilm diffusion coefficients using appropriate coefficients [122]. The
38
diffusion coefficients and the mass transfer rate constant for biomass were obtained
from the validation of the biofilm experimental data.
Table 3.2: Nominal model parameter values
L Biofilm thickness 30 µm [154]
Cb Bulk CO2 concentration 10 mmol/L Specified
Iin Initial photon incidence rate 35 µE/m2s [154]
Nb Nitrate bulk concentration 17.6 mmol/L [158]
Pb Bulk phosphate concentration 1 mmol/L Specified
Gb Bulk glucose concentration 0 mmol/L Specified
Ob Bulk O2 concentration 0.21 mmol/L Specified
DCO2 Diffusion coefficient for CO2 7.9x10−6 cm2/s [122]
DG Diffusion coefficient for glucose 1.8x10−6 cm2/s [122]
DO Diffusion coefficient for oxygen 1.8x10−5 cm2/s [122]
km,co2 CO2 mass transfer coefficient 1x10−4 cm/s Specified
km,i Mass transfer coefficient for glucose and O2 2x10−4 cm/s Specified
vmax,co2 Maximum CO2 uptake rate (mmol/gDW/h) 5 (UCC-A), 5 (UCC-O) Fitted
km,co2 CO2 half saturation constant (mmol/L) 0.5 (UCC-A), 0.5 (UCC-O) Fitted
vmax,photon Maximum Photon uptake rate (mmol/gDW/h) 1.16 (UCC-A), 1.1 (UCC-O) Fitted
km,photon Photon half saturation constant (mmol/L) 0.29 (UCC-A), 0.45 (UCC-O) Fitted
vmax,N Maximum Nitrate uptake rate (mmol/gDW/h) 0.3 (UCC-A), 0.027 (UCC-O) Fitted
km,N Nitrate half saturation constant (mmol/L) 2.7 (UCC-A), 0.001 (UCC-O) Fitted
vmax,P Maximum Phosphate uptake rate (mmol/gDW/h) 0.25 (UCC-A), 0.24 (UCC-O) Fitted
km,P Phosphate half saturation constant (mmol/L) 2 (UCC-A), 10 (UCC-O) Fitted
vmax,G Maximum Glucose uptake rate (mmol/gDW/h) 2.42 (UCC-A), 6.64 (UCC-O) Fitted
km,G Glucose half saturation constant (mmol/L) 1 (UCC-A), 0.5 (UCC-O) Fitted
vmax,O2 Maximum O2 uptake rate (mmol/gDW/h) 20 Fitted
km,O2 O2 half saturation constant (mmol/L) 0.003 Fitted
vmaxh,P Maximum CO2 uptake rate (mmol/gDW/h) 0.25 (UCC-A), 0.42 (UCC-O) Fitted
kmh,P Phosphate half saturation constant (mmol/L) 2 (UCC-A), 0.72 (UCC-O) Fitted
Da Diffusion coefficient for Autotroph (µm2/s) 0.021 (UCC-A), 0.013 (UCC-O) Fitted
Dh Diffusion coefficient for Heterotroph (µm2/s) 0.031 (UCC-A), 0.023 (UCC-O) Fitted
ka,0 Autotroph mass transfer coefficient at L = 0 (µm/s) 0.25 (UCC-A), 0.01 (UCC-O) Fitted
ka,L Autotroph mass transfer coefficient at L = 30 (µm/s) 1 (UCC-A), 0.01 (UCC-O) Fitted
kh,0 Heterotroph mass transfer coefficient at L = 0 (µm/s) 0.6 (UCC-A), 0.053 (UCC-O) Fitted
kh,L Heterotroph mass transfer coefficient at L = 30 (µm/s) 0.98 (UCC-A), 0.42 (UCC-O) Fitted
ktot Photon attenuation coefficient (µ−1) 1x10−3 Fitted
3.3 Results
3.3.1 Biofilm model validation
The autotrophs were able to convert inorganic carbon into glucose and oxygen
in presence of light energy. The glucose and oxygen diffused in the biofilm and
heterotrophs used these as the substrates for their growth and increased their abun-
dances. The phosphate uptake limitations in UCC-A model were added by choosing
αp value (equation 3.4, Model formulation) . The model fittings with and without
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Figure 3.2: Spatially resolved model fitting for UCC-A autotroph-heterotroph biofilms
with (red solid lines) and without (blue lines) nitrate and phosphate limitations. (A)
Autotroph biomass (g/L) at day 14, 21 and 28 for biofilm of thickness L = 30 µm.
(B) Heterotroph biomass (g/L) at day 14, 21 and 28 for biofilm of thickness L = 30
µm.
phosphate uptake limitation were compared. The model predicted that with phos-
phate limitations for day 14 and day 21, the biomass concentrations were higher than
those without phosphate limitations. The day 28 predictions with and without phos-
phate were qualitatively similar. The model fittings were compared at αp = 0.75 and
the fitting parameters were calculated.
Our biofilm model qualitatively captured the experimental behavior of the photoautotroph-
heterotroph biofilms from hot lake (Figure 2 and Figure 3 ). The UCC-A model de-
picted the qualitative peak locations for the day 14 (Figure 3.2A and Figure 3.2B,
top panels) and day 28 (Figure 3.2A and Figure 3.2B, bottom panels) for autotrophs
and heterotrophs. The model also captured the shifting of temporal peak locations
for autotrophs and heterotrophs. The model could not successfully fit the heterotroph
data for day 21 (Figure 3.2B, middle panel). The possible reasons for this data would
be an error in experimental behavior or the lack of details in the modeling framework.
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Figure 3.3: Spatially resolved model fitting for UCC-O autotroph-heterotroph biofilms
with (red solid lines) and without (blue lines) nitrate and phosphate limitations. (A)
Autotroph biomass (g/L) at day 14, 21 and 28 for biofilm of thickness L = 30 µm.
(B) Heterotroph biomass (g/L) at day 14, 21 and 28 for biofilm of thickness L = 30
µm.
The UCC-O model predictions for autotroph and heterotrophs biomass were plot-
ted with and without nitrate and phosphate limitations. The nitrate limitations for
UCC-O was added to incorporate the ability of UCC-O to secrete extracellular poly-
meric substances which puts additional burden on UCC-O metabolism. We chose
αp =0.75 and αn =0.75 to compare the model fittings with and without phosphate
and nitrate uptake limitations. The autotroph biomass concentrations with nitrate
and phosphate limitations were higher as compared with those without nitrate and
phosphate limitations. The heterotroph concentrations without nitrate and phosphate
limitations were higher than those with nitrate and phosphate limitations. The model
fittings improved in presence of nitrate and phosphate limitations as this incorporates
important metabolite exchanges in the system.
The UCC-O model captured the qualitative peak locations for autotrophs and
heterotrophs for day 14 (Figure 3.3A and Figure 3.3B, top panels) and day 28
(Figure 3.3A and Figure 3.3B, bottom panels). The UCC-O model predicted lower
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heterotroph biomass concentrations for day 14, day 21 and day 28 as compared to the
experimental observation. Like UCC-A model, the UCC-O model also successfully
captured the temporal shifts of peak locations for autotrophs and heterotrophs
The models predicted the concentration profiles for the metabolites. We did not
have the experimental data for the metabolites, the metabolite profiles were in line
with previous studies [159–161]. We would be using the fitted the parameters (Table
3.2) to predict the interspecies interactions, species organization, rate of byproduct
formation at various CO2 and photon concentrations.
3.3.2 Effect of CO2
The validated model was used to predict the interactions between autotrophs and
heterotrophs at various CO2 concentrations under restricted phosphate and nitrate
uptakes by autotrophs. Reduced nitrate and phosphate uptakes are observed during
succession for UCC-O and reduced phosphate uptakes were observed for UCC-A [155].
This effect was incorporated by adding parameters for phosphate (αp) and nitrate (αn)
in calculation of uptakes for autotrophs. We chose various values of αp between 0 and
1 and the respective community biomass were calculated. For UCC-A, the biomass
concentration was constant for αp=1, 0.75, 0.5 but it decreased at αp=0.25. In case of
UCC-O the biomass concentration was very sensitive to αp, the concentration dropped
with decrease in αp. Cyanobacterium Phormidium sp. OSCR is known to produce
more extracellular polymeric substances (EPS) than cyanobacterium Phormidesmis
priestleyi ANA. The core metabolic model lacked the fluxes for EPS secretions hence
we have accounted for this behavior by restricting nitrate uptake for autotrophs in
UCC-O by setting αn =0.75. We have considered αp=0.25 for UCC-A and UCC-O and
evaluated the effect of CO2 concentration on community abundances. We varied the
concentration of CO2 supplied at the top of the biofilm (L=0) from 0.1 mmol/L to 10












































































































































































Figure 3.4: Predictions after 14, 21 and 28 days for UCC-A and UCC-O biofilms of
thickness L = 30 µm at various C2 concentration and constant photon incidence (35
µE/m2s). 0.1: CO2 concentration 0.1 mmol/L. 0.5: C2 concentration 0.5 mmol/L.
10: C2 concentration 10 mmol/L. (A) UCC-A: Autotroph biomass concentrations av-
eraged across the biofilm. (B) UCC-A: Heterotroph biomass concentrations averaged
across the biofilm. (C) UCC-A: Glucose concentrations averaged across the biofilm.
(D) UCC-A: Oxygen concentrations averaged across the biofilm. (E) UCC-O: Au-
totroph biomass concentrations averaged across the biofilm. (F) UCC-O: Heterotroph
biomass concentrations averaged across the biofilm. (G) UCC-O: Glucose concentra-
tions averaged across the biofilm. (H) UCC-O: Oxygen concentrations averaged across
the biofilm.
biomass concentrations and average metabolite (glucose and O2) concentrations at
the end of day 14, day 21 and day 28 for UCC-A and UCC-O biofilms.
The average autotroph biomass concentrations for UCC-A increased from day 14
to day 28 for various CO2 concentrations whereas that of heterotrophs decreased
for 0.1 mM of CO2 and increased for all other CO2 concentrations (Figure 3.4A
and 3.4B). The highest autotroph biomass concentration (222.8 g/L at 28 days)
and heterotroph biomass concentration (21.7 g/L at 28 days) were obtained for CO2
concentration 10 mM. This suggests that the CO2 concentration played an important
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role in autotroph growth and biomass accumulation. Autotrophs secreted less amount
of glucose for CO2 level 0.1 mM as compared to CO2 levels 0.5 mM and 10 mM. The
accumulation of glucose at 0.1 mM of CO2 was the least due to its faster consumption
by heterotrophs. O2 secretion increased with increase in supplied CO2. Heterotroph
growth was mainly limited by glucose secretion than that of O2.
For UCC-O, autotroph biomass concentration increased from 79.5 g/L (at day
14) to 93 g/L (at day 28) for all CO2 concentrations considered here (Figure 3.4E).
This indicated that the CO2 was not a limiting substrate for autotroph growth. Exact
opposite trend was observed for heterotroph biomass concentration, it decreased from
20.7 g/L (at day 14) to 17.4 g/L (at day 28) (Figure 3.4F). The accumulation of
glucose increased from day 14 to day 28 whereas that of O2 was constant for all CO2
levels. The model predicted that CO2 concentration doesn’t change the community
composition in UCC-O.
3.3.3 Effect of light incidence rate
The model was further used to predict the impact of photon incidence on the
community stability and dynamics. We evaluated three different photon incidence
rates (10 µE/m2s, 35 µE/m2s and 50 µE/m2s) at constant CO2 concentration (10
mmol/L). The averaged species and metabolite concentrations were plotted at the
end of 14, 21 and 28 days for UCC-A and UCC-O biofilms.
The autotroph concentration in case of UCC-A biofilms increased from day 14 to
day 28 with increase in photon incidence rate from 10 µE/m2s to 50 µE/m2s (Figure
3.5A) with the highest concentration of 282.5 g/L was obtained at day 28 for photon
incidence rate of 50 µE/m2s. The amount of glucose secreted by autotrophs increased
for photon incidence rate of 10 µE/m2s and 35 µE/m2s but it decreased for photon
incidence rate 50 µE/m2s (Figure 3.5C). The amount of O2 secreted by autotrophs
















































































































































































Figure 3.5: Predictions after 14, 21 and 28 days for UCC-A and UCC-O biofilms of
thickness L = 30 µm at various photon incidence rates and constant C2 concentration
(10 mmol/L). 10: photon incidence rate 10 µE/m2s. 35: photon incidence rate 35
µE/m2s. 50: photon incidence rate 50 µE/m2s. (A) UCC-A: Autotroph biomass
concentrations averaged across the biofilm. (B) UCC-A: Heterotroph biomass con-
centrations averaged across the biofilm. (C) UCC-A: Glucose concentrations aver-
aged across the biofilm. (D) UCC-A: Oxygen concentrations averaged across the
biofilm. (E) UCC-O: Autotroph biomass concentrations averaged across the biofilm.
(F) UCC-O: Heterotroph biomass concentrations averaged across the biofilm. (G)
UCC-O: Glucose concentrations averaged across the biofilm. (H) UCC-O: Oxygen
concentrations averaged across the biofilm.
glucose and oxygen efficiently and increased their abundances from 14 g/L (at day
28) to 21.7 g/L (at day 28) for the case of 10 µE/m2s and 35 µE/m2s respectively but
later the abundance decreased to 20.3 g/L (at day 28) for incidence rate 50 µE/m2s
(Figure 3.5B). This suggested that the heterotroph concentration directly depended
on autotroph concentration until photon incidence rate of 35 µE/m2s but later it
decreased for 50 µE/m2s. The autotroph concentration increased with increase in
photon incidence rate.
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The autotroph concentration in case of UCC-O biofilms increased from day 14 to
day 28 with increase in photon incidence rate from 10 µE/m2s to 50 µE/m2s (Figure
3.5E) with the highest concentration of 93.1 g/L was obtained at day 28 for photon
incidence rate of 35 and 50 µE/m2s. The amount of glucose accumulated decreased
for photon incidence rates of 35 µE/m2s and 50 µE/m2s but it increased for photon
incidence rate 10 µE/m2s (Figure 3.5G). The amount of O2 accumulated in biofilm
was constant for all photon incidence rates (Figure 3.5H). Heterotrophs utilized the
glucose and oxygen increased their abundances initially for day 14 but it decreased
due to low glucose availability. Time averaged heterotroph concentration dropped
from 22.4 g/L to 18.7 g/L with increase in photon incidence rate. This suggested
that the photon incidence rate positively affected the autotroph concentrations but
negatively impacted the heterotroph abundances.
3.3.4 Species coexistence
The species coexistence was predicted based on available CO2 and photon inci-
dence rate. We varied supplied CO2 concentration within the range 0.01 mmol/L
and 1 mmol/L. The photon incidence rate was varied from 10 µE/m2s to 50 µE/m2s.
We ran 81 simulations each for UCC-O and UCC-A and plotted the results at the
end of 28 days to find out the conditions feasible for coexistence of autotrophs and
heterotrophs in the community. We concluded that species coexisted if the average
concentration of autotroph was more than 70 g/L and that of heterotroph was at
least 15 g/L.
For UCC-A biofilms, at the lowest photon incidence rate (10 µE/m2s) and at
the lowest CO2 concentration (0.01 mM), the autotroph biomass concentrations were
less than 70 g/L (Figure 3.6A) and that of heterotrophs were less than 15 g/L
(Figure 3.6B). Hence at lowest photon incidence rate (10 µE/m2s) and at lowest
CO2 concentration (0.01 mM), the species could not coexist. At photon incidence
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rate of 15 µE/m2s, the species coexist if CO2 concentration was above 0.05 mM.
The species could coexist for CO2 level 0.075 until the photon incidence rate reached
to 25 µE/m2s. The autotroph biomass increased with increase in photon incidence
rate and increase in CO2 levels. However, the heterotroph biomass concentrations
largely depended on the photon incidence rate, as photon concentration impacts the
secretion of glucose by autotrophs (see Supplementary figure 2). The glucose secretion
increased with increase in CO2 concentrations. The secretion of glucose increased
initially with increase in photon incidence rate, but it decreased later with increase
in incidence rates. This behavior is in line with the typical cyanobacteria metabolism
(Clark et al., 2018). The higher photon incidence rates required high CO2 levels for
species coexistence. The highest autotroph biomass (282.5 g/L) was obtained when
the photon incidence rate was 50 µE/m2s and CO2 concentration was greater than
0.5 mM. The highest heterotroph biomass concentration (22 g/L) was obtained for
photon incidence rate 40 µE/m2s and CO2 concentration greater than 0.5 mM. The
model predicted that the UCC-A community stability will be governed by carbon
availability than the photon incidence rate.
The UCC-O biofilm coexistence map showed that the species cannot coexist at the
lowest CO2 concentration 0.01 mM (Figure 3.6C and 3.6D). At the CO2 concentra-
tion the autotroph biomass was 66.3 g/L and that of heterotroph was 17.2 g/L. Once
the CO2 concentration reaches 0.025 mM, the species coexistence was observed for all
photon incidence rates. The highest autotroph biomass concentration was observed
when photon incidence rate was greater than 20 µE/m2s and CO2 concentration
was higher than 0.05 mM. However, the highest heterotroph biomass was observed
when photon incidence rate was 20 µE/m2s and CO2 concentration was greater than
0.05 mM. Higher concentrations of photon helped autotrophs to increase their abun-
dances, but the heterotroph concentration increased initially with increase in photon
incidence but decreased for higher values of incidence rates. The model predicted
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Figure 3.6: Model predictions for coexistence of autotrophs and heterotrophs for
UCC-A and UCC-O (A) UCC-A: Autotroph biomass concentration (g/L) at various
C2 and photon incidence rates for biofilm of thickness L= 30m. (B) UCC-A: Het-
erotroph biomass concentration (g/L) at various C2 and photon incidence rates for
biofilm of thickness L= 30m. (C) UCC-O: Autotroph biomass concentration (g/L) at
various C2 and photon incidence rates for biofilm of thickness L= 30m. (D) UCC-O:
Heterotroph biomass concentration (g/L) at various C2 and photon incidence rates
for biofilm of thickness L= 30m.
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that the UCC-O community stability will be governed by the photon incidence rate
than the carbon availability.
3.4 Discussion
The cyanobacteria present in the hot lake microbial mat use sunlight and CO2
and produce valuable organic compounds such as glycerol, glucose, ethanol and oxy-
gen. These valuable compounds are further utilized by heterotrophs in the vicinity
and heterotrophs generate CO2 and scavenge toxic compounds. These mutualistic
relationship benefits both the members in the community [162, 163, 15].
We have developed a biofilm model to study the interactions within the autotroph-
heterotroph community found in unicyanobacterial consortia in microbial mat. The
model was developed using core metabolic constructions of UCC-A/UCC-O and a
mixed bag model of 5 dominant heterotrophs. The models were generated in Kbase
database by using the respective genomes of the species. The Kbase database was
further used to gapfill the models and to analyse the growth conditions of the models.
The metabolic models combined with reaction diffusion equations were solved to get
species abundances. We validated the models by using an experimental data available
for photoautotroph-heterotroph community found in microbial mat. The autotrophs
interacted with heterotrophs through metabolite exchanges (glucose and oxygen).
These metabolites were secreted by autotrophs in presence of CO2 and photon.
The models were used to predict the effect of CO2 and photon on interactions
within the community and the species coexistence. UCC-A model predicted that the
autotroph biomass increased by 35%, and the heterotroph biomass by 43% when CO2
concentration increased from 0.1 mM to 10 mM at constant photon rate (35). This
suggested that the CO2 concentration significantly impacted the community biomass
and the species interactions. In case of UCC-O community, CO2 concentration did
not change the individual biomass concentrations, suggesting that the community
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is robust to the change in the concentration of available carbon at constant photon
rate. When we varied the photon rates at constant CO2 concentration (10 mM), we
found that for UCC-A and UCC-O, autotroph biomass increased monotonically. The
heterotroph biomass in UCC-A increased with increase in photon (10 µE/m2s to 35
µE/m2s) but decreased at higher incidence rate (35 µE/m2s). This effect is more
pronounced for heterotrophic community in UCC-O.
The model used for prediction of the species interactions at various depths in
the hot lake environment. The high photon incidence rate would be present at the
lower depths, the photon penetration decreased at higher depths in the lake [164,
165]. Our models captured the species interactions at various depths in hot lake and
predicted the species abundances and coexistence. This will help to further analyse
the species behaviour in the community and role of species in ecology. The complexity
of the models can be further increased by adding more specific interactions such as
chemotaxis. The cyanobacteria are known to secret biofuels and chemicals efficiently
with the help of CO2 and light energy [166–169]. Our models can be used to predict
and evaluate conditions favourable for the higher production of these chemicals and
biofuels by helping in designing of community with maximum interactions.
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CHAPTER 4
METABOLIC MODELING OF CLOSTRIDIUM
DIFFICILE ASSOCIATED DYSBIOSIS OF THE GUT
MICROBIOTA
4.1 Introduction
Numerous experimental studies have demonstrated that C. difficile [170–173] can
form biofilms in vitro. The other commensal bacteria [8, 174] can form biofilms
in vivo which are well known to exhibit phenotypes distinct from planktonic cul-
tures. Mechanistic understanding of the relationships between biofilm spatial vari-
ations, species-species interactions and host-species interactions remains inadequate
to systematically analyze and rationally treat CDI [175]. To address these chal-
lenges, we added C. difficile to our previous multispecies biofilm model [176, 177]
consisting of three representative species from the phyla Bacteroidetes (Bacteroides
thetaiotaomicron), Firmicutes (Faecalibacterium prausnitzii) and Proteobacteria (Es-
cherichia coli). Model simulations were performed to connect host induced nutrient
changes in the gut environment with observed alternations of species abundances and
SCFA levels [178–180] to unravel the metabolic determinants of CDI.
This work is published as: Phalak, Poonam, and Michael A. Henson. “Metabolic Modeling of
Clostridium difficile Associated Dysbiosis of the Gut Microbiota.” Processes 7, no. 2 (2019): 97.
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4.2 Materials and methods
4.2.1 Biofilm model formulation and solution
The multispecies biofilm model was constructed by combining genome-scale metabolic
reconstructions of C. difficile (strain 630∆erm) [181] and three commensal gut species:
B. thetaiotaomicron [182], F. prausnitzii (strain A2-165) [183] and E. coli (strain K-
12 MG1655) [184]. The biofilm was considered to be attached to the colon lining
defined as top of the biofilm (Figure 4.1A). A minimal defined media (MDM) con-
taining glucose, cysteine, isoleucine, leucine, methionine, proline, serine, tryptophan
and valine along with essential vitamins and minerals was used for all simulations.
The amino acids cysteine, isoleucine, leucine, proline, serine and tryptophan are es-
sential for in vivo C. difficile growth [185, 186], while the amino acids methionine,
tryptophan and serine are essential for in vivo F. prausnitzii growth [187]. To simu-
late various host-microbiota perturbations, the primary bile acid taurocholate and/or
the electron acceptor nitrate were added to the media. The diffusion of nutrients,
byproducts and species biomass was assumed to occur only in the axial direction z.
Therefore, each variable was considered to be changing with respect to space z and
time t over a fixed biofilm thickness L.
The nutrients were supplied at the top of the biofilm (Figure 4.1A). SCFAs,
ethanol, organic acids and CO2 produced by the four species were allowed to diffuse
and be removed from both ends of the biofilm. Biomass was assumed to slowly move
through the biofilm by a diffusion and be removed from the biofilm-stool interface
according to a continuous erosion mechanism, as described in our previous publica-
tions [176, 177, 188]. This assumption provided a reasonable mechanism to ensure
that biomass generation would be balanced by biomass loss such that steady-state
solution could be obtained. The multispecies biofilm model was tuned with nominal
glucose and amino acid concentrations to reproduce species abundances and SCFA
levels consistent with experimental studies on healthy individuals [189, 190]. This
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Figure 4.1: Schematic representation of the in silico gut community. (A) The model
assumed biofilm attachment to the intestinal wall and described diffusion of glucose,
amino acids, short-chain fatty acids, organic acids, ethanol, CO2 and species biomass
in and/or out of the biofilm along the axial direction z. (B) Host-microbiota pertur-
bations were modeled through changes in the bulk concentrations of glucose, amino
acids, primary bile acids and nitrate at the biofilm-stool interface to predict species
abundances in healthy and C. difficile infected guts.
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tuned model was referred to as the “healthy case”. Host-microbiota perturbations
were simulated by altering glucose/amino acid concentrations, and/or by introducing
primary bile acids and nitrate as nutrients to predict the resulting species abundances
(Figure 4.1B). These models were collectively referred to as the “dysbiosis case.” In
vivo concentrations of glucose and AA in the guts of healthy and C. difficile infected
patients are not commonly available. We have specified the glucose and AA concentra-
tions for the healthy case based on limited experimental data [28, 191–194] and have
reduced the glucose concentration and increased AA concentrations for the dysbiosis
case consistent with experimental observation [49, 195]. We performed a sensitivity
analysis of these concentrations to show that similar behavior (i.e. healthy state) as
that reported for the nominal values occurs if the glucose to AA ratio was sufficiently
large (not shown here). By contrast, a CDI dysbiosis-like state was obtained when
the glucose to AA ratio was sufficiently small.
Uptake rates of nutrients and byproducts were assumed to followMichaelis-Menten
kinetics. Due to lack of available data, maximum uptake rates and Michaelis-Menten
constants were assumed to be independent of species and metabolite. Calculated
uptake rates were imposed as lower bounds of the exchange fluxes in the species
metabolic reconstructions. The calculated growth rate, uptake fluxes and secretion
fluxes from each reconstruction served as inputs to reaction-diffusion type equations
for the biomass concentration of each species and the molar concentration of each
nutrient and byproduct. This formulation yielded a set of 23 partial differential equa-
tions (PDEs) in time and the axial direction z with embedded linear programs (LPs)
for species metabolism. Following on our previous methodology [176, 177], lexico-
graphic optimization with growth rate maximization as the primary objective was
used to avoid alternative optima that would render the biofilm model non-smooth.
This approach yielded a total of 71 LPs.
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The biofilm model equations were solved by spatially discretizing the PDEs into a
large set of ordinary differential equations (ODEs) [93, 141]. We used 25 spatial node
points to achieve a suitable compromise between solution accuracy and computational
efficiency, which produce a discretized model with 575 ODES and 1,775 LPs that
was solved with the MATLAB code DFBAlab [126]. We used Gurobi 6.5.2 for LP
solution, the stiff MATLAB solver ode15s for ODE integration and DFBAlab running
in MATLAB 9.0 (R2016a).
4.2.2 Biofilm model parameterization and tuning
Nominal parameter values used in the multispecies biofilm model are shown in
Table 4.1. The parameters were obtained from the experimental literature to extent
possible and from our previous modeling studies [176, 177] as necessary. The bulk
glucose and amino acid concentrations at the biofilm-stool interface were specified
to reflect healthy gut conditions. Due to lack of species-specific uptake data, we
used published kinetic parameters reported for E. coli [114]. Due to lack of data, all
eight byproducts were assumed to have the same uptake parameters as glucose. For
simplicity, all eight amino acids were assumed to have the same uptake parameters
obtained as the average of amino acid dependent values reported for E. coli [114].
With all other parameter values fixed, the biofilm model was qualitatively tuned
to achieve biomass and SCFA fractions within experimental ranges for a healthy
patient. The species abundances were tuned by adjusting the non-growth associated
ATP maintenance (ATPM) values of the four metabolic reconstructions following our
previous studies [176, 177]. Our justification for tuning these values was the simple
nature of the biofilm model, which neglected other phyla (e.g. Actinobacteria), other
nutrients (e.g. oligosaccharides, fats), other species interactions (e.g. Actinobacteria
cross feeding of SCFAs and organic acids) as well as host metabolism present in
the actual gut environment. These ATPM values listed in Table 4.1 produced B.
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thetaiotaomicron:F. prausnitzii:E. coli:C. difficile abundances of 71%:21%:7%:1%,
which were deemed reasonable based on published data [189, 190]. We found that
coexistence of the four species was achieved over a range of ATPM values (not shown
here).
We adjusted the SCFA mass transfer coefficients controlling metabolite removal
from the biofilm to tune the acetate, butyrate and propionate concentrations for the
healthy case. Starting with a value of 5x10−6 cm/s, the butyrate and propionate
values were decreased until approximate fractions of 60%:20%:20% consistent with
published data [21, 196] was obtained. We justified the use of SCFA-dependent val-
ues by noting that our model neglected host-microbiota interactions which would be
expected to strongly affect SCFA levels in vivo. Biofilm simulations were performed
for four combinations of bulk glucose, amino acid, nitrate and taurocholate concen-
trations chosen to mimic a healthy gut environment and three unhealthy nutrient
environments (high amino acids, high primary bile acids, high nitrate) experimen-
tally correlated to C. difficile associated dysbiosis (Table 4.2). We deemed the actual
concentrations used to be less important than the concentration trends (e.g. decreas-
ing glucose and increasing amino acids in the high amino acids case) since our goal
was to qualitatively assess the effects of nutrient levels on community behavior.
4.3 Results
4.3.1 Discovery of putative byproduct crossfeeding relationships
Our previous modeling study [176] without C. difficile generated three byproduct
crossfeeding relationships that were predicted to be necessary and sufficient for coexis-
tence of the three species: B. thetaiotaomicron consumption of ethanol secreted by E.
coli and F. prausnitzii consumption of acetate and succinate secreted by B. thetaio-
taomicron and E. coli. Preliminary flux balance analysis (FBA) with the C. difficile
reconstruction showed acetate, butyrate and propionate were the major byproducts
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Table 4.1: Nominal parameter values for the multispecies biofilm model.
Symbol Parameter Value Source
L Biofilm thickness(µm) 40 [85]
Xb Biomass bulk concentrations (g/L) 0 [176]
Pb Byproduct bulk concentrations (mmol/L) 0 [176]
Di Diffusion coefficient (cm2/s)
DX Biomass 2x10−10 [176]



















Mass transfer coefficient (cm/s)
kX Biomass 6x10−7 [176]
kN Glucose 2x10−4 [176]
Amino acid 2x10−4 [176]





vmax Maximum uptake rate (mmol/gDW/h)
Glucose 10 [114]
Amino acid 1 [114]
Byproduct 10 [176]
Km Michaelis-Menten constant (mmol/L)
Glucose 0.5 [114]
Amino acids 0.1 [114]
Byproduct 0.5 [176]
ATPM ATP maintenance (mmol/gDW/h)
B. thetaiotaomicron 4.25 Tuned
F. prausnitzii 3.4 Tuned
E. coli 2.75 Tuned
C. difficile 8.43 Tuned
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Table 4.2: Nutrient concentrations used for healthy and three dysbiosis simulation
cases in mmol/L.






Glucose 8.0 4.0 8.0 4.0
Cysteine 0.5 1.0 0.5 1.0
Isoleucine 0.5 1.0 0.5 1.0
Leucine 0.5 1.0 0.5 1.0
Methionine 0.5 1.0 0.5 1.0
Proline 0.5 1.0 0.5 1.0
Serine 0.5 1.0 0.5 1.0
Tryptophan 0.5 1.0 0.5 1.0
Valine 0.5 1.0 0.5 1.0
Nitrate 0 0 0 0.4
Taurocholate 0 0 1.5 1.5
and succinate and formate could be uptaken as carbon sources in the presence of
glucose. With this knowledge, the four-species biofilm model was analyzed to dis-
cover additional crossfeeding relationships that support C. difficile coexistence with
the three commensal species. Each species was allowed to consume glucose, the eight
amino acids and any available byproduct (acetate, CO2, ethanol, formate, lactate and
succinate) assuming no differences in uptake kinetics across species and byproducts
(see Materials and Methods). Simulations with a biofilm thickness of 40 microns and
bulk concentrations of 8 mmol/L glucose and 0.5 mmol/L each amino acid at the
biofilm-stool interface corresponding to the healthy case (Table 4.2) were run for 300
hours to ensure a steady-state solution consistent with a mature biofilm was obtained.
A particular crossfeeding relationship was deemed significant if at least one uptake
or secretion flux exceeded 1 mmol/gDW·h.
The biofilm model predicted significant crossfeeding of acetate, ethanol, formate
and succinate between the four species (Figure 4.2A). Lactate and CO2 crossfeeding
were insignificant. Importantly for this study, C. difficile was predicted to: (1) con-
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sume formate secreted by F. prausnitzii and E. coli; (2) compete with F. prausnitzii
for succinate secreted by B. thetaiotaomicron; and (3) synthesize acetate for consump-
tion by F. prausnitzii (Figure 4.2B). Experimentally, C. difficile has been shown to
uptake succinate and produce butyrate [197] and to produce acetate by consuming
formate directly or indirectly by uptaking CO2 and H2 [198]. Consequently, we hy-
pothesized that formate and succinate crossfeeding could play a role in C. difficile
propagation in vivo.
To test community stability and robustness in the absence of C. difficile, the
same simulation was performed with the initial C. difficile biomass concentration set
to zero. The resulting three-species community remained stable with B. thetaiotaomi-
cron:F. prausnitzii:E. coli abundances of 66%:27%:7% consistent with a healthy gut
community. These predictions were aligned with our previous study [176].
4.3.2 Characterization of healthy gut microbiota
With the putative crossfeeding relationships (Figure 4.2B) included, the multi-
species biofilm model was simulated for a biofilm thickness of 40 microns and the
healthy nutrient levels (Table 4.2). The model was tuned such that the mature biofilm
obtained after 300 hours of simulation produced B. thetaiotaomicron:F. prausnitzii:E.
coli:C. difficile abundances of 71%:21%:7%:1% when averaged across the biofilm (see
Materials and Methods). These abundances were consistent with data from in vivo
studies [189, 190].
We analyzed species biomass concentrations (Figure 4.3A) and local growth rates
(Figure 4.3B) with respect to location in the biofilm with nutrients supplied at the
biofilm-stool interface (z = 0). C. difficile was predicted to have the highest growth
rates in the nutrient-rich bottom half of the biofilm but the lowest growth rates in the
nutrient-lean top half. The local growth rates of the three commensal bacteria were
comparable across the biofilm, with B. thetaiotaomicron having the highest growth
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Figure 4.2: Predicted cross feeding of byproducts between the four species. (A)
Species exchange rates specified in mmol/gDW/h. Secretion rates are positive and
uptake rates are negative. (B) Byproduct cross-feeding patterns identified from the
species uptake and secretion fluxes in Figure 4.2 A.
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Figure 4.3: Predicted multispecies biofilm behavior in the absence of host-microbiota
perturbations. (A) Species biomass concentrations across the thickness of the biofilm
with nutrients supplied and biomass removed at z = 0 microns. (B) Local species
growth rates across the thickness of the biofilm. (C) Acetate, butyrate, propionate
and total SCFA concentrations averaged across the biofilm. (D) Ethanol, succinate,
formate and total OA levels averaged across the biofilm.
rates in the bottom half and F. prausnitzii having a slight advantage in the top
half. Due to its growth advantage in the nutrient-rich bottom half and slow cellular
diffusion, B. thetaiotaomicron produced much higher biomass concentrations across
the entire biofilm. F. prausnitzii and E. coli established lower biomass concentrations,
while C. difficile was present at small concentrations due to its very small growth rate
in the nutrient-lean top half. The spatial distributions of supplied nutrients, species
biomass and secreted byproducts were similar to those reported in our previous studies
[176, 177] and are omitted here. This simulation suggests that the commensal bacteria
can sublimate C. difficile propagation through nutrient competition and may help
explain how healthy individuals can be asymptomatically colonized.
The biofilm model also was tuned for healthy nutrient levels to produce ac-
etate:propionate:butyrate fractions of 60%:20%:20% when averaged across the biofilm
to be consistent with in vivo studies [21, 196] (See Materials and Methods). The model
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predicted the total SCFA concentration to be 32.5 mmol/L (Figure 4.3C), which was
in reasonable agreement with an in vivo study with control diet that yielded 41.1
mmol/L of total SCFAs [199]. One possible explanation for the lower SCFA levels
predicted by our model is the simplified diet (glucose, eight amino acids) compared
to the control diet used experimentally.
Ethanol was present at a very low level (Figure 4.3D) due to limited synthesis by
the small E. coli population and high consumption by the large B. thetaiotaomicron
population. Of the two organic acids (OAs) produced, formate was predicted to be
present at a high level because synthesis by F. prausnitzii and E. coli substantially
exceeded consumption by C. difficile. Succinate was present at a moderate level since
it was consumed by both C. difficile and F. prausnitzii. These predictions suggest that
plentiful formate and succinate could be available to promote C. difficile propagation
under in vivo perturbations.
4.3.3 Glucose and amino acid perturbations
Various in vivo studies have shown that glucose concentration decreases and amino
acid concentrations increase in the gut during C. difficile and other types of dysbio-
sis [28, 191–194]. To investigate the effects of altered nutrient levels associated with
host-microbiota perturbations, we performed simulations for a 40 micron biofilm with
elevated amino acid and reduced glucose bulk concentrations (Table 4.2) under the
assumption that C. difficile expansion is driven by these experimentally-observed nu-
trient changes. While in vivo nutrient levels are impacted by diet, host metabolism
and microbiota, this assumption was deemed reasonable given the simplified nature
of our model. Given the uncertainty associated with the bulk nutrient concentra-
tions, we performed a sensitivity analysis to explore their effects .with respect to the
species abundances (not shown here). This analysis was consistent with the model
predictions reported below as long as the glucose to amino acid ratio was sufficiently
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Figure 4.4: Predicted multispecies biofilm dysbiosis resulting from host-microbiota
perturbations in glucose and amino acid concentrations. (A) Change in species growth
rates across the biofilm plotted as the difference between the growth rates for the
healthy and dysbiosis cases. (B) Biomass concentrations (bar graphs) and species
abundances (pie chart) averaged across the biofilm for healthy and dysbiosis case.
(C) Acetate, butyrate, propionate and total SCFA concentrations averaged across
the biofilm. (D) Succinate, formate and total OA concentrations averaged across the
biofilm.
large. Compared to the healthy case, the local C. difficile growth rate decreased in
the bottom half of the biofilm but increased in the top half (Figure 4.4A). Similar
trends were predicted for the three commensal species, which we attributed to re-
duced glucose but increased amino acid penetration into the biofilm. C. difficile is
known to grow efficiently on amino acids due to its ability to use amino acid pairs
such as leucine and proline to generate ATP via Stickland metabolism [200, 185, 186].
As a result of its enhanced growth in the top half of the biofilm compared to the
commensal species, C. difficile increased its average biomass concentration ten-fold
and species abundance from 1% to 22% compared to the healthy case (Figure 4.4A).
The biomass concentration of each commensal species dropped due to reduced glucose
availability. A substantial effect was predicted for F. prausnitzii with its species
abundance decreasing from 21% to 12%, partially due to increased competition for
succinate with C. difficile. These predictions are in agreement with in vivo studies
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[45, 201–203], with the exception that dysbiosis during CDI should be accompanied
by an increase in E. coli abundance [29, 31, 204–206]. The model predicted reduced
total biomass production due to reduced growth of the three commensal species.
Dysbiosis was predicted to result in increased acetate, decreased butyrate and pro-
pionate, and lower total SCFA levels compared to the healthy case (Figure 4.4C). We
attributed reduced total SCFA synthesis to lower glucose availability and increased
acetate and decreased butyrate levels to a change in the balance of acetate-producing
C. difficile and acetate-to-butyrate converting F. prausnitzii. Experimental stud-
ies have shown that dysbiosis is associated with reduced butyrate concentrations in
the gut [202, 207]. The model predicted large changes in organic acid levels, with
succinate, formate and total OA concentrations dropping due to reduced glucose fer-
mentation. These predictions suggest that the combination of decreased carbohydrate
and increased amino acid levels could play a role in C. difficile associated dysbiosis.
4.3.4 Primary bile acid perturbations
Primary bile acids such as taurocholate are secreted by the liver and transported
into the intestines where anaerobic bacteria degrade them into secondary bile acids
[208–210]. Broad spectrum antibiotics are known to reduce gut microbiota diver-
sity [46–49, 211], including the possible loss of bacterial species from families Lach-
nospiraceae and Ruminococcaceae responsible for conversion of primary bile acids.
Various in vitro [212, 210, 213] and in vivo [32, 214] studies have shown that C.
difficile spores can use primary bile acids for germination. Sodium taurocholate is
the typical reagent used to grow C. difficile in vitro [215, 216]. We investigated the
impact of such perturbations with the multispecies biofilm model by adding tauro-
cholate as a representative primary bile acid (Table 4.2). While primary bile acids are
known to promote C. difficile transition from spores to a vegetative state [212, 217],
we assumed that C. difficile was already vegetative and investigated the effect of
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taurocholate on C. difficile growth. Preliminary FBA calculations with the C. diffi-
cile metabolic reconstruction showed that taurocholate uptake increased the growth
rate, while taurocholate uptake was not possible with the three commensal species
reconstructions.
Compared to the healthy case, the introduction of taurocholate was predicted
to increase the local C. difficile growth rate across the biofilm (Figure 4.5A). B.
thetaiotaomicron and E. coli growth were largely unaffected, while the F. prausnitzii
growth rate decreased due to increased competition for succinate from C. difficile. As
a result, the C. difficile abundance increased from 1% to 18%, while the F. prausnitzii
abundance decreased by 38% (Figure 4.5B). The B. thetaiotaomicron and E. coli
abundances exhibited relatively small decreases, although experimental studies show
that E. coli abundance should increase during dysbiosis [204, 206]. The total biomass
concentration was predicted to remain almost constant, showing that taurocholate
was responsible for changing the species distribution of the biomass.
The predicted trends for SCFA and OA levels were similar to those observed for
the combined glucose/amino acid perturbation. Acetate and total SCFA concentra-
tions increased compared to the healthy case due to increased acetate synthesis by
C. difficile and decreased acetate consumption by F. prausnitzii (Figure 4.5C). The
formate concentration decreased because of the same mechanism, while we attributed
the reduced succinate concentration to increased succinate consumption by C. difficile
(Figure 4.5D). Butyrate (produced by F. prausnitzii and C. difficile) and propionate
(produced by B. thetaiotaomicron and C. difficile) concentrations remained almost
constant as C. difficile compensated for reduced SCFA synthesis by the two com-
mensal species. We also simulated a host-microbiota perturbation with decreased
glucose/increased amino acids and increased taurocholate to examine the combined
effects of these nutrient changes. Compared to either perturbation alone, the model
predicted a further increase in C. difficile abundance and decrease in F. prausnitzii
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Figure 4.5: Predicted multispecies biofilm dysbiosis resulting from host-microbiota
perturbations in the concentration of the primary bile acid taurocholate. (A) Change
in species growth rates across the biofilm plotted as the difference between the growth
rates for the healthy and dysbiosis case. (B) Biomass concentrations (bar graphs) and
species abundances (pie charts) averaged across the biofilm for healthy and dysbiosis
case. (C) Acetate, butyrate, propionate and total SCFA concentrations averaged
across the biofilm. (D) Succinate, formate and total OA concentrations averaged
across the biofilm.
abundance (not shown here). Overall, these results support the hypothesis that in-
creased primary bile acid levels could contribute to C. difficile propagation in vivo.
4.3.5 Host-derived nitrate perturbations
The human host is known to secrete nitrate in response to inflammation in the
gut [33]. Preliminary FBA calculations showed that nitrate uptake increased the
E. coli growth rate, while the other three community members were unable to use
nitrate as an electron acceptor. Therefore, we hypothesized that host-derived nitrate
would increase E. coli abundance during simulated C. difficile associated dysbiosis
and yield better agreement with experimental studies [204, 206]. To quantify the
effects of nitrate availability, biofilm simulations were performed with and without
nitrate for a dysbiosis case with reduced glucose, increased amino acids and available
taurocholate (Table 4.2).
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Figure 4.6: Predicted multispecies biofilm dysbiosis with and without host-derived
nitrate. (A) Biomass concentrations (bar graphs) and species abundances (pie charts)
averaged across the biofilm for healthy and dysbiosis case. (C) Acetate, butyrate,
propionate and total SCFA concentrations [mmol/L]averaged across the biofilm. (D)
Succinate, formate and total OA concentrations averaged across the biofilm.
As hypothesized, the main impact of host-derived nitrate was to substantially
increase E. coli abundance from 4% without nitrate to 20% with nitrate (Figure 4.6A).
The F. prausnitzii abundance decreased from 7% to 2%, while the abundances of B.
thetaiotaomicron and C. difficile decreased modestly to accommodate the increased
E. coli. The species abundances predicted with nitrate are in good agreement with
experimental studies for C. difficile associated dysbiosis showing large increases in
C. difficile and E. coli, large decreases in F. prausnitzii and modest changes in B.
thetaiotaomicron [218–220].
Nitrate availability was predicted to substantially increase the acetate and total
SCFA concentrations due to large changes in E. coli and F. prausnitzii abundances
(Figure 4.6B). Decreased succinate consumption by F. prausnitzii and increase for-
mate synthesis by E. coli results in increase levels of individual and total OAs (Figure




The gut microbiota serve a broad array of important functions for the human
host, including providing colonization resistance to opportunistic pathogens. Un-
healthy changes in the microbiota composition, commonly termed dysbiosis, have
been correlated to a wide variety of gut and metabolic diseases including inflamma-
tory bowel disease, Crohn’s disease, obesity, diabetes and chronic gut infections. The
opportunistic gut pathogen Clostridium difficile has been estimated to asymptomat-
ically colonize 3%–15% of healthy adults [44]. A common cause of symptomatic C.
difficile infection (CDI) is the use of broad spectrum antibiotics, which induce dys-
biosis by reducing the diversity and density of gut commensal bacteria that provide
resistance to C. difficile expansion [46–49, 211]. Improved understanding of the com-
plex interactions between commensal species, C. difficile, the gut environment and
the human host are needed to more rationally treat CDI.
To help unravel the metabolic determinants of C. difficile associated dysbiosis,
we developed a multispecies biofilm model by combining genome-scale metabolic re-
construction of C. difficile [181] and commensal species representing the three domi-
nant phyla in the gut: Bacteroides thetaiotaomicron (Bacteroidetes) [182], Faecalibac-
terium prausnitzii (Firmicutes) [183] and Escherichia coli (Proteobacteria) [184]. The
chosen species are well-studied representatives of the most dominant phyla in human
gut microbiome and curated metabolic reconstructions of these species are available.
While specific spatial organization of gut microbes is currently unknown, the structure
likely includes biofilm growth associated with host mucosa and epithelial tissue [221].
The literature provides significant evidence to support the hypothesis that some gut
microbes develops spatially structured multispecies biofilms [174, 172]. We sought
to understand how the commensal species could sublimate C. difficile expansion and
under what gut conditions colonization resistance could become compromised. The
biofilm model was tuned to represent a healthy state with species abundances and
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concentrations of short-chain fatty acids (SCFAs; acetate, butyrate, propionate) con-
sistent with experimental studies for healthy individuals [21, 196, 189] Because our
model lacked an explicit description of the human host, we mimicked host-microbiota
perturbations associated with CDI by varying nutrient levels guided by experimental
observations. More specifically, dysbiosis states were modeled through changes in
the concentrations of available glucose, amino acids [28, 191–194], primary bile acids
[32, 214, 210] and nitrate [33].
Our model predicted that crossfeeding of secreted byproducts plays an important
role in C. difficile sublimation and expansion. C. difficile consumed formate synthe-
sized by F. prausnitzii and E. coli and succinate synthesized by B. thetaiotaomicron
and F. prausnitzii. The existence of both crossfeeding relationships is supported by
the experimental literature [197, 198]. In silico removal of either crossfeeding rela-
tionship was predicted to provide C. difficile colonization resistance, demonstrating
the complexity and importance of crossfeeding networks even in this simplified four-
species community. More importantly, these results suggest therapeutic strategies
that target species-species interactions could be promising alternatives to conven-
tional antibiotics that target C. difficile directly.
Host-microbiota perturbations modeled as increases in glucose and decreases in
amino acid concentrations reproduced several feature of C. difficile associated dysbio-
sis including substantially reduced F. prausnitzii and increased C. difficile abundances
and an imbalance in SCFA synthesis characterized by increased acetate and reduced
butyrate levels [222]. The predicted decrease in anti-inflammatory butyrate would be
expected to exasperate dysbiosis and accelerate disease progression [202, 207]. Sim-
ilar predictions were obtained when glucose and amino acid changes were replaced
by increases in the primary bile acid taurocholate, which can be used as an electron
acceptor by C. difficile in vivo to provide a growth advantage in the absence of com-
mensal bacteria that degrade primary bile acids to secondary bile acids [191, 223, 224].
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Taurocholate availability was predicted to have less effect on butyrate and propionate
synthesis, but the SCFA imbalance remained due to high acetate synthesis. Our
model predicted that dysbiosis could be induced with moderate changes in nutrient
concentrations, suggesting the possible promise of therapeutic strategies that aim to
alter the gut nutritional environment.
Despite their many consistencies with experimental studies [28, 225, 226], our sim-
ulations with glucose, amino acids and taurocholate changes were unable to reproduce
the large increase in E. coli abundance observed during CDI [204, 206]. The addition
of host-derived nitrate [33, 227] to the other nutrient changes rectified this inconsis-
tency and reproduced the key microbiota signatures of C. difficile associated dysbiosis
during CDI: large increases in C. difficile and E. coli abundances, large decreases in
health-promoting F. prausnitzii abundance and moderate changes in B. thetaiotaomi-
cron abundance. We believe further development of our multispecies biofilm model
could yield a general computational platform for in silico investigation of CDI, other
gut infections and chronic inflammation disorders such as inflammatory bowel and
Crohn’s diseases. Some possibilities include the modeling of C. difficile spore forma-
tion/germination, the inclusion of more commensal gut species (e.g. [228]) including
those from other phyla [229–231], the addition of a broader array of gut nutrients in-
cluding fibers, oligosaccharides and fats resulting from realistic diets [28–31, 232], and
modeling of the human host through incorporation of available metabolic reconstruc-
tions such as Recon 2 or Recon 3D [233–235]. A possible drawback of our modeling
approach is the lack of species-specific parameters for nutrient uptake kinetics and
metabolite-dependent mass transfer coefficients.
4.5 Conclusions
Clostridium difficile infection (CDI) is a common problem in hospital settings,
with almost 500,000 CDI cases diagnosed within the U.S. annually in acute care facil-
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ities alone. CDI involves dysbiosis of the commensal gut microbiota characterized by
a significant reduction of butyrate producing species e.g. Faecalibacterium prausnitzii
and a large increase in Proteobacteria e.g. Escherichia coli along with uncontrolled
propagation of C. difficile. Motivated by recent experimental studies demonstrating
the ability of C. difficile and commensal gut bacteria to form biofilms, we developed
a multispecies biofilm model with a minimal representation of the gut microbiota
containing C. difficile and one species each from the three dominant phyla (F. praus-
nitzii, E. coli, Bacteroides thetaiotaomicron). The model was used to investigate
possible metabolic determinants of CDI mediated through host-microbiota perturba-
tions, modeled as decreased carbohydrate levels and increased amino acid, primary
bile acid and nitrate levels compared to the healthy gut. These nutrient perturba-
tions were shown to mimic microbiota changes characteristic of CDI, namely marked
increases in C. difficile and E. coli, abundances and a sharp decrease in F. praus-
nitzii abundance. C. difficile propagation was strongly dependent on crossfeeding of
formate and succinate secreted by the commensal species, a prediction in agreement
with experimental studies and that provides possible targets for the development of
novel therapeutic strategies. While our model is a simplified representation of a com-
plex disease process, the results presented emphasized the importance of metabolic
interactions between C. difficile and commensal species in CDI progression.
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CHAPTER 5
METABOLIC MODELING OF CHRONIC WOUND
MICROBIOTA PREDICTS MUTUALISTIC
INTERACTIONS THAT DRIVE COMMUNITY
COMPOSITION
5.1 Introduction
Chronic wounds are usually colonized by microbial communities rather than single
bacterial species [54–56, 65, 66]. Polymicrobial infections often require about 12+
months to clear, have recurrence frequencies of 60 to 70% [236, 237] and have elevated
mortality rates as compared to single-species infections [67]. In vivo rabbit models
have demonstrated that polymicrobial infections slow wound healing compared to
their respective monoculture infections [61, 68].
Culture- and molecular-based methods have been used to analyze chronic wound
communities [62, 238, 239]. The most common genera represented in chronic wound
infections are Staphylococcus, Corynebacterium, Pseudomonas, Streptococcus, Ente-
rococcus, Enterobacter, Finegoldia and Serratia [54, 55, 65, 240–243]. Staphylococcus
aureus and Pseudomonas aeruginosa are the two most common bacterial pathogens
observed in chronic wound infections. These two pathogens have been shown to es-
tablish mutualistic interactions including metabolite crossfeeding that allows them
to resist antibiotic treatment in multiple types of infection environments including
chronic wounds and the cystic fibrosis lung [244, 118, 245, 246]. Mutualistic rela-
tionships between pathogens reduce competition for available nutrients and result in
robust communities associated with prolonged infections and poor clinical outcomes
[247]. Chronic wound pathogens also form mutualistic relationships with skin com-
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mensal species that impact their virulence [248, 139, 249]. These interactions allow
pathogens to survive at infection sites, enhance antibiotic resistance and increase dis-
ease severity [57, 250, 149, 251]. More detailed knowledge about the mechanisms
underlying these interspecies relationships offers the potential for developing novel
treatment strategies based on disrupting specific mutualistic interactions rather than
just targeting specific pathogens.
In this study, We have used our in silico computational methods and 16S rDNA
pyrosequencing data collected from 2,963 chronic wound patients [1] to develop a
bacterial community model for investigation of pathogen-pathogen and pathogen-
commensal interactions. The dataset contained abundances (i.e. the relative amount
of the genera averaged across samples) of the 20 most abundant genera for each
type of chronic wound, diabetic foot ulcers, venous leg ulcers, pressure ulcers and
non-healing surgical wounds, as well as prevalences (i.e. the fraction of samples
containing the genus). Because the original study [1] concluded that the average
bacterial community present at each wound location were not significantly different,
the average abundance data for each wound type was assimilated into a combined
dataset and used to construct a single 12 species community model representing the
most abundant pathogenic and commensal genera. Simulation results were performed
and analyzed to identify putative mutualistic interactions that could drive community
composition and negatively impact the effectiveness of antibiotic treatments.
5.2 Materials and methods
5.2.1 Community metabolic model
16S rDNA pyrosequencing data was obtained from a published study which an-
alyzed chronic wound samples from 2,963 patients treated for decubitus ulcers (767
samples), diabetic foot ulcers (910 samples), venous leg ulcers (916 samples) and
non-healing surgical wounds (370 samples) [1]. The publication provided relative
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Table 5.1: The 12 species included in the chronic wound community model along with
the prevalences and normalized average abundances of the associated genera from [1].
Number Strain References Prevalence (%) Relative abundance
1 Staphylococcus aureus subsp aureus USA300 FPR3757 [238, 239, 1] 63 0.42
2 Pseudomonas aeruginosa NCGM2 S1 [238, 239, 1] 25 0.13
3 Corynebacterium striatum ATCC 6940 [54, 238, 1] 36 0.11
4 Streptococcus agalactiae A909 [238, 1] 23 0.07
5 Enterococcus faecalis V583 [239, 252] 17 0.05
6 Finegoldia magna ATCC 29328 [54, 1] 25 0.05
7 Anaerococcus vaginalis ATCC 51170 [238, 253] 24 0.05
8 Stenotrophomonas maltophilia D457 [238, 1] 19 0.04
9 Prevotella bivia DSM 20514 [1, 253] 12 0.03
10 Acinetobacter baumannii AB0057 [238, 253] 9 0.02
11 Serratia liquefaciens ATCC 27592 [62, 254] 5 0.02
12 Bacteroides fragilis 3 1 12 [253, 255] 8 0.02
abundances of the top 20 bacterial genera for each wound types. Community com-
position was shown to be independent of the wound type and patient demographics
such as age, gender and race. Therefore, we assimilated the average abundance data
for each wound type into a single dataset and determined the most abundant genera
across all samples. To limit model complexity and focus on the most dominant genera,
the community model accounted for the 12 genera with highest average abundances
(Figure 5.1A). These 12 genera accounted for approximately 74% of the 16S read
data averaged across all 2,963 samples. To allow direct comparison with community
model predictions, the 16S data was normalized such that the abundances of these 12
genera summed to unity. A representative species for each genus was selected from
the AGORA database (www.vmh.life) [77] according to its documented presence in
chronic wound infections (Table 5.1). The genome-scale metabolic reconstructions
for the 12 species accounted for 16,133 reactions, 13,666 metabolites and 9,713 genes.
5.2.2 Model tuning and simulation
The nutrient environment in chronic wound is complex and expected to vary be-
tween patients and according to disease progression. A metabolomics study conducted
for four chronic pressure ulcer samples detected 122 metabolites with the quantified
metabolite concentrations spanning several orders of magnitude. Several studies have
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Figure 5.1: Overview of the community modeling framework. (A) Flow chart showing
steps in model development, simulation and analysis. (B) Average species abundances
obtained from the model ensemble. (C) r and p values obtained from correlation anal-
ysis of the model ensemble abundance data. (D) Significant crossfeeding relationships
between Staphylococcus and Pseudomonas predicted by model ensemble simulations.
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identified upregulated or downregulated metabolites in chronic wounds compared to
healing wounds, but absolute metabolite concentrations were not reported [256–258].
The in vitro Lubbock chronic wound biofilm model based on chopped meat-based
media (Bolton broth, MRS broth and BHI broth) has been shown to contain nutri-
ents present in chronic wound beds [259]. While these studies provided important
guidance on nutrient selection for the community model, they were not sufficient
to completely define a nutrient environment in which all 12 species were capable of
growth and the predicted species abundances were in approximate agreement with
the 16S data [1] used in this study.
Therefore, our approach previously used to specify nutrients for a community
model of the adult cystic fibrosis microbiota [76] was followed. First, all 21 amino acids
and 6 carbon sources (glucose, L-lactate, ribose, galactose, L-arabinose, fructose)
known to be available in chronic wound beds were added. Then 15 common metals
and ions and 30 metabolites that were required for each species to grow in simulated
monoculture were included. The metabolites guanosine, inosine, uracil and uridine
[256, 257] and the terminal electron acceptors O2 and NO3 were added because they
are known to be present in the chronic wound environment. Finally, three putative
metabolites were added to increase the growth rates of particular species such that
predicted species abundances were in approximate agreement with the 16S data:
starch 1 for Corynebacterium; kestose for Enterococcus and; glycerol-3-phosphate for
Prevotella.
The 81 metabolites contained in the simulated chronic wound environment were
partitioned into 19 groups for the purpose of model tuning: (1) 15 metals and ions;
(2) 30 essential growth metabolites; (3)-(6) each of the 4 chronic wound metabolites
guanosine, inosine, uracil and uridine: (7) 17 amino acids; (8) 4 amino acids isoleucine,
leucine, lysine and valine reported to be elevated in chronic wounds compared to the
other 17 amino acids [258]; (9)-(14) each of the 6 carbon sources; (15) O2; (16)
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NO3; (17) starch 1; (18) kestose; and (19) glycerol-3-phosphate. The community
uptake rates of metabolites in these 19 groups were tuned by trial-and-error to achieve
approximate agreement with the 16S data (see Figure 5.1C).
The SteadyCom method [74] was used to formulate and solve the chronic wound
community model as described in our previous studies on the human gut microbiota
[75] and cystic fibrosis [76]. The SteadyCom method uses a form of community
flux balance analysis to calculate the relative abundance of each species with an
objective of maximizing the community growth rate. The non-growth associated ATP
maintenance for each species was chosen to be 5 mmol/gDw/h, which is in reported
ranges for curated bacterial reconstructions [184]. Individual species simulations were
performed to ensure that each species was able to grow in monoculture on the in silico
media. In addition to providing the community growth rate and species abundances,
SteadyCom calculated species-dependent uptake and secretion rates of all supplied
and secreted metabolites.
The community model was further constrained with genus prevalence data (i.e.
the fraction of samples containing the genus) available in the original experimental
study [1]. To implement these constraints, the participating species of the community
were randomly chosen according to the prevalences using uniform random numbers
and then the model was solved. A large number of models were solved to adequately
sample the species participation space. A total of 5,250 model ensemble simulations
were performed with 250 cases discarded because the community growth rate was
zero or the SteadyCom tolerance on the sum of the species abundances was not
satisfied. The remaining 5,000 cases were treated as simulated patient samples and
their abundances were averaged (Figure 5.1B). The community uptake rates of the
81 supplied metabolites were further tuned to achieve quantitative agreement with
the 16S data (see Figure 5.1D).
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5.2.3 Analysis of simulation results
The difference (e) between the normalized 16S abundances (pid) and the model










where ‖ · ‖ denote the Euclidean norm and e ∈ [0, 1]. The two abundance vectors
were identical (i.e. parallel) if e = 0 and orthogonal if e = 1. The inverse Simpson









where N = 12 is the total number of species and pi is the 16S determined or model
predicted abundance of the species i. Significant crossfeeding relationships were iden-
tified based on the magnitudes of the secretion and uptake fluxes as detailed in our
previous study [75]. We typically reported the top six crossfeeding relationships be-
tween the participating species (Figure 5.1D).
Staphylococcus and Pseudomonas are the most common genera in chronic wound
infections [65, 61, 243, 261–263] and are known to exhibit strong interactions. Cor-
respondingly, we were interested in community behavior with the presence and ab-
sence of these two dominant pathogens. Therefore, the ensemble of 5,000 commu-
nity simulations was partitioned into four groups: both Staphylococcus and Pseu-
domonas present (SaPa); Pseudomonas not present (Sa∆Pa); Staphylococcus not
present (∆SaPa); and neither Staphylococcus or Pseudomonas present (∆Sa∆Pa).
For the entire ensemble and each of the four partitioned subsets, mutualistic in-
teractions between species were identified by performing correlation analysis on the
predicted abundance data (Figure 5.1C). An interaction was deemed significant if the
r-value was greater than 0 and p-value was less than 0.05.
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5.3 Results
5.3.1 Community composition is shaped by single-species metabolism
Monoculture simulations were performed with the in silico nutrients to access the
metabolic capabilities of the 12 species. Staphylococcus was predicted to have the
highest single-species growth rate (Figure 5.2A), consistent with its role as a dom-
inant chronic wound pathogen. Serratia, Stenotrophomonas and Pseudomonas had
growth rates greater than 0.3 h−1, suggesting that these species would be competitive
in community simulations. Of 9 metabolites commonly found in the chronic wound
environment [256], acetate, CO2 and formate were the primary secreted byproducts
predicted from monoculture simulations (Figure 5.2B). Interestingly neither L-lactate
or D-lactate secretion was predicted even though species from genera such as Strep-
tococcus are well known to secrete L-lactate as a primary byproduct [264, 265]. As
discussed in our study on cystic fibrosis communities [76], this model behavior was
attributable to alternative optima with respect to byproduct secretion patterns.
When the community model was simulated without prevalence constraints, 7 of
the 12 species were predicted to coexist (Figure 5.2C). Consistent with the normal-
ized 16S data, Staphylococcus was the dominant species and both Pseudomonas and
Corynebacterium) were present at abundances greater than 10%. However, the model
overpredicted the abundances of Acinetobacter, Serratia and Bacteroides and incor-
rectly predicted zero abundances for 5 other species. The difference e between the
predicted and 16S abundance vectors was 0.38, denoting a moderate prediction error.
This difference was not unexpected, as the 16S data was provided as the average
over a large number of patient samples while the simulation represented a single pre-
dicted sample [76]. As a result, the normalized 16S data exhibited a greater species
diversity (Dcom = 0.38) than the simulated sample (Dcom = 0.36). The predicted
species abundances were strongly correlated to the single-species growth rates (r =
0.72, p = 0.009; Figure 5.2D), as expected for a community modeling method such
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Figure 5.2: Model predictions for monoculture simulations and a 12 species commu-
nity simulation without prevalence constraints. (A) Single-species growth rates (h−1)
where the species are listed by their genera. (B) Single-species secretion rates pre-
dicted from monoculture simulations for the byproducts acetate (Ac), CO2, ethanol
(Eth), formate (For), H2S, D-lactate (D-Lac), L-lactate (L-lac), NH4 and succinate
(Succ). (C) Comparison of species abundances predicted from the 12 species commu-
nity model without prevalence constraints and obtained from normalized 16S patient
data. (D) Relationship between single-species growth rates and species abundances
predicted from the community simulation (r = 0.72, p = 0.009).
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as SteadyCom based on growth rate maximization. An sublinear correlation was
predicted because some species were more/less efficient at metabolite crossfeeding.
For example, Pseudomonas had the fourth highest monoculture growth rate but the
second highest abundance.
5.3.2 Incorporation of genera prevalence data improves prediction of
community composition
A single model simulation with all 12 species allowed to participate in the commu-
nity only provided qualitative agreement with normalized 16S data with respect to the
abundances of the dominant genera (Figure 5.2). We hypothesized that incorporation
of genera prevalence data as additional constraints would improve model predictions
with respect to the coexisting species and their abundances. Given that the 16S
abundances were obtained by averaging over 2,963 patient samples, we used preva-
lence data reported in the original study [1] to generate an ensemble of 5,000 in silico
communities by randomly generating the species allowed to participate (see Materi-
als and Methods). Then the predicted abundances were averaged over the ensemble
for comparison to 16S values. This approach was consistent with the constraints-
based philosophy of metabolic modeling based on the refinement of model predic-
tions through the imposition of additional data-based constraints [266, 267]. Even
if allowed to participate in a community, a particular species could be predicted to
have a zero abundance. Therefore, participation was a necessary but not sufficient
condition for a species to coexist in a simulated community. Below we used the terms
“prevalence” and “participation” interchangeably with respect to the model ensemble
simulations for simplicity.
A comparison of the genera prevalence data and the in silico prevalences of the
corresponding modeled species showed a slight bias even through the model ensemble
was generated with the intent of these prevalences being identical (Figure 5.3A). This
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Figure 5.3: Prevalence constrained model ensemble predictions. (A) Comparison of
genera prevalence data [1] and in silico prevalences of the corresponding modeled
species. (B) Comparison of species abundances predicted from the model ensemble
with species prevalence constraints and normalized 16S patient data.
disparity was caused by the need to discard 250 of 5,250 total simulation cases be-
cause the community growth rate was zero or the SteadyCom tolerance on the sum of
the species abundances was not satisfied. The removal of these 250 cases introduced
a small systematic bias into the in silico prevalences as most species were advantaged
by being allowed to participate more frequently than indicated by data. Despite
this small bias, the model ensemble generated substantially improved predictions of
the 16S-derived abundances (e = 0.12; Figure 5.3A) compared to the prevalence un-
constrained model (e = 0.38; Figure 5.2). As expected, the model prevalences and
abundances were strongly correlated (r = 0.91, p = 5x10−5). While the abundances
of some minor species were substantially underpredicted (e.g. Enterococcus) or over-
predicted (e.g. Bacteroides), we deemed these prediction to be sufficiently accurate
to utilize the model ensemble for further analysis of the chronic wound community.
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5.3.3 Analysis of community structure and composition
We defined the richness of the community as the number of species with abun-
dances exceeding 1%. To further investigate the effect of imposing prevalence con-
straints in the ensemble of 5,000 models, we calculated the number of species allowed
to participate in each community (Figure 5.4A) and the actual richness of each com-
munity (Figure 5.4B). Over 90% of the simulations allowed no more than 4 species,
with the most likely cases being 2 or 3 species. Because some species allowed to par-
ticipate were predicted to have zero abundances, the predicted richness was generally
less than the number of participating species. Over 90% of the simulated communities
had richnesses of no more than 3 species. Therefore, the model ensemble predicted
that most individual patient samples would have low diversity. The original study [1]
did not provide data on individual samples that would allow comparison with these
modeling results.
Because Staphylococcus and Pseudomonas are the two dominant pathogens in
chronic wound infections [65, 61, 243, 261–263], we partitioned the ensemble of 5,000
community models into four groups based on the allowed participation of these two
species (see Materials and Methods): both Staphylococcus and Pseudomonas present
(SaPa); Pseudomonas not present (Sa∆Pa); Staphylococcus not present (∆SaPa); and
neither Staphylococcus or Pseudomonas present (∆Sa∆Pa). Each group was popu-
lated by a sufficient number of models to allow statistical analysis of the impact of
each dominant pathogens on community structure and species interactions (Figure
5.4C). The SaPa group was predicted to have the highest average growth rate with
little variability except for some outliers (Figure 5.4D). The growth rate decreased
and variability increased as Pseudomonas (Sa∆Pa), Staphylococcus (∆SaPa) or both
species (∆Sa∆Pa) were removed from the communities. These predictions suggest
mutualistic interactions between the two pathogens and possibly with some commen-
sal species that enhance community fitness.
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Figure 5.4: Analysis of chronic wound community structure and growth rates. (A)
The number of species allowed to participate in each community simulation. (B)
The richness (number of species with calculated abundances exceeding 1%) of each
simulated community. (C) The percentages and numbers of the 5,000 simulated
models in which both Staphylococcus and Pseudomonas were allowed to participate
(SaPa),Pseudomonas was not allowed to participate (Sa∆Pa); Staphylococcus was
not allowed to participate (∆SaPa); and neither Staphylococcus or Pseudomonas were
allowed to participate (∆Sa∆Pa). (D) A box and whisker plot showing the community
growth rates for each of the four partitioned cases, where the red line corresponds
to the median, the black dotted lines (whiskers) indicate the variability outside the
lower upper quartiles, and the red circles represent outliers.
84
Interestingly, all outlier communities were characterized by high growth rates with
the exception of the ∆Sa∆Pa group. We analyzed the compositions of these outliers
for each group by comparing predicted abundances of the outlier communities to
those of communities with outliers removed (not shown here). This analysis revealed
several putative mutualistic relationships including: Serratia and/or Bacteroides with
Staphylococcus and/or Pseudomonas; and Streptococcus with Finegoldia. The outlier-
free cases for the ∆Sa∆Pa group were predicted to have much higher diversity than
the other groups, suggesting that the presence of Staphylococcus and/or Pseudomonas
increased community growth at the expense of diversity. These predictions were
consistent with our previously posited hypothesis that infectious disease progression
correlates to high growth and low diversity of the evolving community [75].
5.3.4 Staphylococcus and Pseudomonas form a mutualistic relationship
We used the ensemble of 820 community models in which both dominant pathogens
Staphylococcus and Pseudomonas could participate (SaPa) to identify putative mu-
tualistic interactions between the 12 modeled species. The only significant mutual-
istic relationship predicted was between the two pathogens themselves (Table 5.2),
suggesting that this interaction drove community growth and composition. We per-
formed additional analysis to test this hypothesis. Compared to the average species
abundances calculated from the entire 5,000 model ensemble, the 820 SaPa cases pro-
duced a much larger Pseudomonas abundance such that the abundances of the two
dominant pathogens averaged almost 90% (Figure 5.5A). The Pseudomonas abun-
dance was greater than the Staphylococcus abundance in 780 communities (Figure
5.5B), indicating that Pseudomonas was the primary beneficiary of the mutualistic
interaction.
The SaPa model ensemble predicted a significant positive correlation (r = 0.53,
p < 10−6) between community equitability and growth rate (Figure 5.5C). These
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Figure 5.5: Model ensemble predictions for SaPa simulations showing a mutualistic
relationship between Staphylococcus and Pseudomonas. (A) Average species abun-
dances for all 5,000 ensemble simulations and 820 SaPa simulations. (B) Staphylo-
coccus and Pseudomonas abundances for 820 simulated communities containing both
species where the colorbar indicates the number of simulations represented by each
circle. The two species show a mutualistic interaction (r = 0.69, p < 10−6). (C)
Community growth rates and equitability for 820 simulated communities containing
both species. (D) The six most significant crossfeeding relationships between the two
species.
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Table 5.2: Species abundance correlation analysis.
Group Positively correlated species r value p value Number of cases Analysis
SaPa Staphylococcus and Pseudomonas 0.69 <10e-6 820 Figure 5.5
Sa∆Pa Staphylococcus and Acinetobacter 0.57 <10e-6 235 Figure 5.6
Sa∆Pa Staphylococcus and Corynebacterium 0.22 <10e-6 895 Not shown
Pa∆Sa Pseudomonas and Serratia 0.88 <10e-6 18 Figure 5.7
Pa∆Sa Pseudomonas and Streptococcus 0.72 <10e-6 125 Not shown
Pa∆Sa Pseudomonas and Acinetobacter 0.41 <10e-2 42 Not shown
Pa∆Sa Pseudomonas and Bacteroides 0.4 <1e-2 39 Not shown
∆Sa∆Pa Corynebacterium and Stenotrophomonas 0.6 <10e-6 107 Not shown
∆Sa∆Pa Corynebacterium and Serratia 0.5 <1e-2 24 Not shown
∆Sa∆Pa Corynebacterium and Bacteroides 0.6 <10e-6 41 Not shown
∆Sa∆Pa Streptococcus and Enterococcus 0.53 <10e-6 51 Figure 5.8
∆Sa∆Pa Streptococcus and Acinetobacter 0.46 <10e-3 30 Not shown
∆Sa∆Pa Streptococcus and Serratia 0.61 <1e-1 12 Not shown
∆Sa∆Pa Streptococcus and Bacteroides 0.92 <10e-6 30 Not shown
∆Sa∆Pa Enterococcus and Finegoldia 0.78 <10e-6 66 Not shown
∆Sa∆Pa Enterococcus and Stenotrophomonas 0.3 <1e-2 63 Not shown
∆Sa∆Pa Enterococcus and Acinetobacter 0.91 <10e-6 25 Not shown
∆Sa∆Pa Enterococcus and Bacteroides 0.98 <10e-6 18 Not shown
∆Sa∆Pa Finegoldia and Anaerococcus 0.75 <10e-6 85 Not shown
∆Sa∆Pa Finegoldia and Acinetobacter 0.63 <10e-6 40 Not shown
∆Sa∆Pa Finegoldia and Serratia 0.86 <10e-6 17 Not shown
∆Sa∆Pa Finegoldia and Bacteroides 0.51 <1e-2 20 Not shown
∆Sa∆Pa Anaerococcus and Stenotrophomonas 0.49 <10e-6 73 Not shown
∆Sa∆Pa Anaerococcus and Acinetobacter 0.8 <10e-6 35 Not shown
∆Sa∆Pa Anaerococcus and Bacteroides 0.54 <10e-2 28 Not shown
∆Sa∆Pa Stenotrophomonas and Acinetobacter 0.5 <10e-2 29 Not shown
∆Sa∆Pa Stenotrophomonas and Bacteroides 1 <10e-6 20 Not shown
∆Sa∆Pa Prevotella and Bacteroides 0.7 <1e-2 12 Not shown
∆Sa∆Pa Serratia and Bacteroides 0.83 <1e-2 8 Not shown
results suggest that the incorporation of less abundant commensal species such as
Corynebacterium enhanced community growth. When combined with predictions
that the SaPa ensemble produced the highest growth rates with the lowest variability
(Figure 5.4D), these predictions indicate that the mutualistic interaction produced
resilient communities not negatively affected by the addition of commensal species.
The mutualistic relationship between Pseudomonas and Staphylococcus was supported
by bi-directional metabolite crossfeeding, with ethanol, L-lactate and succinate being
the primary crossfed metabolites (Figure 5.5D). Interestingly, L-lactate and D-lactate
were not secreted by either species in monoculture (Figure 5.2B) due to alternative
optima with respect to byproducts. These predictions suggest that the exchange
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of these two byproducts was important for maintaining the interaction. In fact,
Staphylococcus is known to consume lactate in vivo to enhance its competitiveness
[268].
5.3.5 Staphylococcus and Acinetobacter form a mutualistic relationship
in the absence of Pseudomonas
Next we used the ensemble of 2,410 community models in which Pseudomonas was
absent (Sa∆Pa) to predict mutualistic interactions between Staphylococcus and the
10 remaining species. Compared to the entire 5,000 model ensemble (Figure 5.6A),
the 2,140 Sa∆Pa simulations produced a substantially higher average Staphylococ-
cus abundance and richer communities in which only Enterococcus and Finegoldia
failed to coexist (Figure 5.6A).Two mutualisms involving Staphylococcus were iden-
tified (Table 5.2); we focused on the Staphylococcus and Acinetobacter relationship
(Figure 5.6B) because the correlation was most positive (i.e. mutualistic) and ex-
perimental literature characterizing the interaction was available. Compared to the
SaPa cases (Figure 5.5A), the absence of Pseudomonas resulted in increased average
Acinetobacter abundance over the 235 cases in which Acinetobacter was allowed to
participate.
A significant positive correlation (r = 0.53, p < 10−6) between community equi-
tability and growth rate was predicted for the Sa∆Pa model ensemble (Figure 5.6C),
suggesting that commensals such as Streptococcus enhanced community growth. How-
ever, the Sa∆Pa ensemble produced lower growth rates than the SaPa ensemble
(Figure 5.4D) due to the absence of Pseudomonas. Therefore, increased richness of
the Sa∆Pa ensemble was accompanied by decreased growth. These predictions are
consistent our hypothesis that low abundance of dominant pathogens such as Pseu-
domonas corresponds to an earlier disease stage with relatively low growth and high
diversity [75]. Compared to the mutualistic interaction between Staphylococcus and
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Figure 5.6: Model ensemble predictions for Sa∆Pa simulations showing a mutualistic
relationship between Staphylococcus and Acinetobacter. (A) Average species abun-
dances for all 5,000 ensemble simulations and 2,410 Sa∆Pa simulations. (B) Staphy-
lococcus and Acinetobacter abundances for 235 simulated communities in which both
species could participate where the colorbar indicates the number of simulations rep-
resented by each circle. The two species showed a mutualistic interaction (r = 0.57,
p < 10−6). (C) Community growth rates and equitability for 235 simulated com-
munities with both species. (D) The five most significant crossfeeding relationships
between the two species.
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Pseudomonas in the SaPa ensemble (Figure 5.6D), Pseudomonas and Acinetobac-
ter mutualism was supported by lower crossfeeding rates of amino acids rather than
organic acids and alcohols. Acinetobacter was predicted to be the primary benefi-
ciary of crossfeeding, explaining its ability to coexist with Pseudomonas absent. This
predicted mutualistic relationship has experimental support, as Staphylococcus and
Acinetobacter are major nosocomial pathogens involved in burn infections [269–271]
and both genera are known to develop antibiotic resistance [272]. These predictions
could yield new insights into the treatment of the so-called ESKAPE pathogens (En-
terococcus faecalis, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter bau-
mannii, Pseudomonas aeruginosa, Enterobacter species) which are the leading cause
of nosocomial infections [272, 273].
5.3.6 Pseudomonas and Serratia form a mutualistic relationship in the
absence of Staphylococcus
The ensemble of 506 community models in which Staphylococcus was absent (∆SaPa)
was analyzed to predict mutualistic relationships between Pseudomonas and the 10
remaining species. The ∆SaPa simulations produced a high average Pseudomonas
abundance and a large increase in the average abundance of Anaerococcus (Figure
5.7A); only Finegoldia failed to appear in any community. Of the four significant
mutualistic relationships predicted (Table 5.2), we focused on Pseudomonas and Ser-
ratia even though the two species were both allowed to participate in only 18 ∆SaPa
communities (Figure 5.7B). Interestingly, the average Serratia abundance was almost
unchanged from the full model ensemble despite Serratia having a positive correlation
with Pseudomonas. Furthermore Anaerococcus did not have a significant correlation
with Pseudomonas despite Anaerococcus having a larger average abundance compared
to the full model ensemble. These results demonstrate that significant species inter-
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Figure 5.7: Model ensemble predictions for ∆SaPa simulations showing a mutualistic
relationship between Pseudomonas and Serratia. (A) Average species abundances
for all 5,000 ensemble simulations and 506 ∆SaPa simulations. (B) Pseudomonas
and Serratia abundances for 18 simulated communities in which both species could
participate where the colorbar indicates the number of simulations represented by
each circle. The two species showed a mutualistic interaction (r = 0.88, p < 10−6).
(C) Community growth rates and equitability for 18 simulated communities with
both species. (D) The six most significant crossfeeding relationships between the two
species.
actions cannot easily be discerned from abundance data averaged over heterogeneous
samples.
A significant positive correlation (r = 0.95, p < 10−6) between community equi-
tability and growth rate was predicted for the ∆SaPa model ensemble despite the
small number of samples (Figure 5.6C). The mutualistic relationship was primarily
supported by lactate crossfeeding, with Serratia having a large uptake rate of L-lactate
and Pseudomonas consuming D-lactate (Figure 5.6D). The ability of Serratia to en-
hance its competitiveness through L-lactate crossfeeding explains why Serratia was
predicted to be dominant in the 18 ∆SaPa communities in which it appeared (Figure
5.6B). Pseudomonas and Serratia are often found to coexist in infections associated
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with chronic wounds and corneal ulcers [54, 274]. Furthermore, the two genera are
known to secrete the quorum sensing molecule N-butanoyl l-homoserinelactone (C4
HSL) which might be used in interspecies communication [275].
5.3.7 Streptococcus and Enterococcus form a mutualistic relationship in
the absence of Pseudomonas and Staphylococcus
To identify putative mutualistic interactions between less abundant species, we
analyzed the ensemble of 1,264 community models in which both Staphylococcus and
Pseudomonas were absent (∆Sa∆Pa). This ensemble produced lower and more vari-
able growth rates than the other ensembles due to lack of the two dominant, growth-
promoting pathogens (Figure 5.4). This growth reduction was accompanied by an
increase in community richness as all 10 remaining species were able to coexist in
some communities and no species was predicted to have an average abundance less
than 3% (Figure 5.8A). This enhanced richness translated into higher equitabilities
than predicted for the other ensembles (Figure 5.8C), again supporting the hypothesis
that pathogen emergence results in resilient communities characterized by increased
growth and reduced diversity.
Rather than focus on mutualisms with respect to a single species, we used the
∆Sa∆Pa simulation results to identify mutualistic relationships between any pair of
the 10 remaining species (90 possible cases). The analysis produced 23 significant
interactions (Table 5.2), suggesting that mutualistic benefits could be spread across
more species in the absence of dominant pathogens. For example, the commensal
Corynebacterium positively interacted with less abundant pathogen Stenotrophomonas.
We focused on the mutualistic relationship between Streptococcus and Enterococcus
(Figure 5.8B) because these two genera are known to coexist in infections [276, 277].
As before, the community growth rate and equitability were positively correlated (r =
0.49, p = 10−5, Figure 5.8C) in the 51 communities in which both species could par-
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Figure 5.8: Model ensemble predictions for ∆Sa∆Pa simulations showing a mu-
tualistic relationship between Streptococcus and Enterococcus. (A) Average species
abundances for all 5,000 ensemble simulations and 1,264 ∆Sa∆Pa simulations. (B)
Streptococcus and Enterococcus abundances for 51 simulated communities in which
both species could participate where the colorbar indicates the number of simulations
represented by each circle. The two species showed a mutualistic interaction (r =
0.53, p < 10−6). (C) Community growth rates and equitability for 51 simulated com-
munities with both species. (D) The four most significant crossfeeding relationships
between the two species.
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ticipate. The two species interacted through the crossfeeding of multiple metabolites
(Figure 5.8D), with L-lactate consumption important for Enterococcus coexistence.
Streptococcus and Enterococcus are known to form thick and dense biofilms on root
canal dentin and glass slides [277]. Furthermore, Enterococcus has been shown to be
more resistant to starvation in coexistence with Streptococcus [277], an interaction
our model attributed to L-lactate crossfeeding.
5.4 Discussion
Polymicrobial infections in chronic wounds are responsible for poor clinical out-
comes and cause elevated mortality rates as compared to single-species infections
[252]. Colonizing species establish mutualistic relationship through multiple mecha-
nisms including metabolite crossfeeding to promote community stability and resilience
[137, 139, 278]. Robust community structures mitigate the effectiveness of antibiotic
treatments and promote the evolution of antibiotic resistance through mechanisms
such as horizontal gene transfer [279, 280]. The communities place an increasing
bioburden on the host and play a critical role in impaired/delayed wound healing
[281–283]. While recent studies based on 16S rRNA [284] and rDNA [285, 1] sequenc-
ing have revealed key bacterial taxa involved in chronic wound infections, knowledge
about the interspecies mechanisms that drive community structure and function have
remained elusive.
We developed a 12 species community metabolic model to identify putative in-
teractions that drive the composition of chronic wound communities. The 12 bac-
terial species covered 74% of 16S rDNA pyrosequencing reads of genera from 2,963
chronic wound patients [1]. We used the limited data available from chronic wound
metabolomics studies [256–258] as a starting point to define community uptake rates
as required in the SteadyCom modeling framework [74]. Model tuning was used to de-
fine 81 host-derived nutrients and their uptake rates such that each species was capa-
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ble of monoculture growth and predicted species abundances were in rough agreement
with normalized 16S values from the original study [1]. The tuning process required
the introduction of 30 metabolites to achieve monoculture growth and three putative
chronic wound metabolites to enhance the growth rates of particular species: starch
1 (Corynebacterium), kestose (Enterococcus) and glycerol-3-phosphate (Prevotella).
As discussed in our previous modeling study on cystic fibrosis communities [76], the
30 essential metabolites suggests limitations for the AGORA genome-scale metabolic
models [77] with respect to biosynthetic pathways leading to biomass formation. The
presence of the three growth-enhancing metabolites in chronic wound beds would
need to be tested through metabolomics.
The tuned single-species models offered a wide range of predicted metabolic capa-
bilities with respect to their growth rates and metabolite secretion patterns (Figure
2). As found in our previous modeling studies on gut [75] and cystic fibrosis [76]
communities, pathogens such as Staphylococcus, Pseudomonas and Stenotrophomonas
generally had higher growth rates than commensal species, suggesting that they are
more metabolically capable of dominating the community. When compared to nor-
malized 16S-derived abundances averaged across the 2,963 patients, the tuned com-
munity model predicted relatively high abundances for the most highly represented
genera (Staphylococcus, Pseudomonas, Corynebacterium) but underpredicted or over-
predicted abundances of the remaining genera and generated a relatively low diversity
community.
We sought to improve the prediction of community composition by imposing gen-
era prevalence data available from the original study [1] as additional in silico con-
straints. The prevalence data was used to generate an ensemble of 5,000 communities
in which the participating species of each community were randomly determined.
While the in silico prevalences averaged over the 5,000 simulations deviated slightly
from the 16S-derived values (see Materials and Methods), the average species abun-
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dances predicted by the prevalence-constrained model ensemble showed substantially
improved agreement (Figure 3). These results demonstrate the difficulties in predict-
ing 16S-derived abundances averaged over large numbers of patient samples with a
single community model that is best thought of as simulating a single patient sample.
Because Staphylococcus and Pseudomonas are the dominant pathogens observed
in most chronic wound infections [65, 263, 262, 61, 243, 261], we were interested in
community behavior in the presence and absence of these two pathogens. To over-
come the lack of individual patient sample data in the original study [1], the ensemble
of 5,000 community simulations was partitioned into four groups: both Staphylococ-
cus and Pseudomonas allowed to participate (SaPa, 820 cases); Pseudomonas not
allowed to participate (Sa∆Pa, 2,410 cases); Staphylococcus not allowed to partic-
ipate (∆SaPa, 506 cases); and neither Staphylococcus or Pseudomonas allowed to
participate (∆Sa∆Pa, 1,264 cases). We sought to computationally identify mutu-
alistic relationships between species for each of the four scenarios since mutualisms
reduce competition for available nutrients and result in robust communities associated
with prolonged infections and poor clinical outcomes [62]. These putative mutualis-
tic interactions were viewed as future targets for experimental testing and possible
therapeutic disruption to enhance treatment efficacy.
When the pathogens Staphylococcus and Pseudomonas were allowed to partici-
pate in communities, the only significant mutualistic relationship predicted was be-
tween the two pathogens themselves. These SaPa communities were characterized
by pathogen dominance, low diversity and high growth rates with little variability
(Figure 5), characteristics we previously attributed to resilient communities well pro-
gressed towards a fully developed disease state [75, 76]. Mutualism was supported
by bi-directional crossfeeding of organic acids, amino acids and ethanol between the
two species, making the identification of a single crossfeeding relationship for dis-
ruption a challenge. These predictions are supported by studies showing that the
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presence of Pseudomonas along with Staphylococcus generates larger chronic wounds
and delays/prevents the healing process [286, 287, 65, 288].
In the absence of Pseudomonas, Staphylococcus was predicted to form mutualis-
tic relationships with the less abundant pathogen Acinetobacter and the commensal
Corynebacterium. By spreading mutualism across two pairs of species, the Sa∆Pa
ensemble produced slightly more diverse communities at the expense of slower and
more variable growth (Figure 6). These results suggest that infections lacking Pseu-
domonas should be more easily treated, a hypothesis supported by the aforemen-
tioned studies [286, 287, 65, 288]. The Staphylococcus–Acinetobacter interaction was
driven by lower metabolite crossfeeding rates than those predicted for Staphylococcus
and Pseudomonas, another indication that Pseudomonas-free infections should be
more easily cleared. These predictions could yield new insights into the treatment of
the so-called ESKAPE pathogens (Enterococcus faecalis, Staphylococcus aureus, Kleb-
siella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, Enterobacter
species) which are the leading cause of nosocomial infections [272, 273].
When Staphylococcus was omitted from the simulated communities, Pseudomonas
was predicted to have mutualistic relationships with four other species: Serratia,
Streptococcus, Acinetobacter and Bacteroides. Consistent with the trends mentioned
above, this increase in the number of mutualistic interactions resulted in the ∆SaPa
ensemble producing more diverse communities which exhibited slower and more vari-
able growth (Figure 6). The effect of removing Staphylococcus in the Sa∆Pa communi-
ties was greater than the effect of removing Pseudomonas in the Sa∆Pa communities,
consistent with the role of Staphylococcus as the single dominant pathogen in chronic
wound infections whose absence correlates to better clinical outcomes [289, 61]. The
Pseudomonas-Serratia interaction was primarily driven by L-lactate and D-lactate
exchange between the two species, a prediction that could be tested through in vitro
experiments.
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Of the 90 pairwise interactions possible when both Staphylococcus and Pseu-
domonas were removed, 22 interactions were predicted to be significantly mutualistic.
The ∆Sa∆Pa ensemble exhibited substantially higher diversity and lower and more
variable growth than the other three ensembles, consistent with earlier stage infec-
tions that lack dominant pathogens. One particularly interesting mutualistic rela-
tionship involved the commensal Streptococcus and ESKAPE pathogen Enterococcus,
which has some experimental support [277]. Our model predicted that this inter-
action was driven largely by L-lactate consumption by Enterococcus, demonstrating
how pathogens may take advantage of metabolic byproducts secreted by commensals
to increase their abundance when more dominant pathogens are absent.
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CHAPTER 6
CONCLUSIONS AND FUTURE WORK
6.1 Summary
The metabolic modeling framework (Figure 6.1) was developed to study inter-
species interactions and to evaluate the impact of host environment on the interspecies
interactions in the multispecies biofilms. Steady state community metabolic models
were developed by identifying dominant genera from 16S patient data. These models
were solved using SteadyCom method where community growth rate is maximized
and the relative species abundances, cross feeding rates and byproduct secretion rates
were obtained. These models can be used to identify mutualistic interactions from
multispecies communities. The mutualistic interactions play important role in species
pathogenesis and disease progression. The developed metabolic modeling framework
is capable of mapping individual patient data for devising patient specific antibiotic
treatments.
To study the heterogeneity in the biofilm system caused by concentration gra-
dients, the spatiotemporal biofilm metabolic models were developed. These mod-
els were used to study spatial/temporal organization of the species and interspecies
interactions such as crossfeeding, species inhibition and nutrient competition. The
biofilm models were formulated by combining genome scale metabolic reconstructions
of considered species and transport equations for species biomass and nutrient con-
centrations. The models were solved by using dynamic flux balance approach. This
is a powerful tool as the concentration gradients in the biofilms drive the dynamics
of the interspecies interactions and spatial organization.
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Figure 6.1: Overview of multispecies biofilm metabolic modeling.
Taken together, the steady state models use 16S patient data to predict robust
mutualistic interactions which further can be studied with the help of spatiotemporal
models to analyze the underlying causes of treatment failures. These insights would
be helpful in designing better antibiotic treatments.
6.2 Future Work
Two species chronic wound biofilm model can be extended by developing a model
bacterial consortia system comprised of three clinical chronic wound isolates: aerobic
Pseudomonas aeruginosa, facultative anaerobe Staphylococcus aureus and obligate
anaerobe Clostridium perfringens [86]. This consortium would be ideal for developing
and validating the necessary computational and analytical methods for investigating
the recalcitrance of chronic wound biofilms. The existing chronic wound biofilm model
can be modified by adding genome scale metabolic reconstruction of a third species
Clostridium perfringens. The model can be further extended by adding reaction-
diffusion equation for supplied antibiotics. The model can be initially limited to a
single antibiotic at a time. The species biomass equations can be modified to include
growth inhibition and cell death terms mediated by the antibiotics. For simplicity,
the model can be initially limited to a single antibiotic at a time. The species biomass
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equations can be modified to include growth inhibition and cell death terms mediated
by the antibiotics. The antibiotic uptake kinetics, inhibited growth rate and death
rate will depend on the local antibiotic concentrations. The simulation results can be
validated with experimental observations.
Multispecies community models can be developed for studying interactions be-
tween gut microbiota and Clostridium difficile during CDI associated dysbiosis. The
relative abundance data obtained for healthy case and dysbiosis case along with mu-
tualistic relationships within the community would be useful in understanding the
CDI and develop antibiotic therapy. This community modeling framework would
also be useful in identifying the metabolic differences in gut microbiota of healthy
person and C. difficile infected patient.
The metabolic model predictions are dependent on the species uptake kinetics
(vmax and km). Due to lack of species specific nutrient uptake kinetics, we have
used parameters obtained from E. coli. The model predictions are also dependent
on diffusion and mass transfer coefficients of species, metabolites and byproducts.
Experiments can be performed to obtain the species specific nutrient uptake parame-
ters. The dissolved oxygen levels and the pH gradients in the biofilm will significantly
change the coexistence map of the species and hence experiments can be performed to
get these profiles. Further, the computational model can be extended to account the
changes in pH by fitting the profiles obtained from experiments and the predictions
of species concentrations can be improved.
The spatiotemporal model can be extended to account for spatial expansion or
contraction in case of biofilm development or treatment. Biofilm expansion can be
assumed to be driven by the relative rates of cell growth and death. Cell growth
increases the local biomass concentration and cell death leads to decrease in biomass
concentration. This extension would be useful in predicting the biofilm metabolism
over expanding/contracting thicknesses.
101
The biofilm systems are assumed to be in laminar flow and model predictions
can be improved by adding an impact of shear force on the removal of biomass cells.
The mass transfer occurring at air-biofilm interface can be modeled as a two phase
mass transfer and the boundary conditions can be changed based on this correction.
The air-biofilm mass transfer coefficients can be calculated by developing a simple
computational fluid dynamic model for in vitro system of well plates. The results
from computational study can be validated from the in vitro experiments.
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